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  Retinoic Acid Receptor Signaling During Paraxial Mesoderm  
Differentiation of Pluripotent Stem Cells 
 
Ryan Patrick Russell, PhD 
University of Connecticut, 2018 
 
The treatment of severe musculoskeletal injuries is currently limited to surgical 
intervention and natural healing during recovery, which are not always sufficient to repair critical 
defects. Various cell-based approaches for repair augmentation have gained traction, however 
a reliable cell therapy approach has not been realized.  Pluripotent stem cells (PSCs) retain the 
developmental potential to become any cell in the human body and are a valuable model for 
studying cell differentiation that hold tremendous promise for treating orthopedic injuries.  The 
goal of our research has been to develop an efficient in vitro differentiation method to generate 
skeletal progenitor cells, the forerunners of osteoblasts, chondrocytes and tenocytes, 
responsible for creation and maintenance bone, cartilage and tendon, respectively.  We have 
focused on generating paraxial mesoderm, a specific type of mesoderm whose derivatives give 
rise to all cell types comprising the axial skeleton.  Our approach progressively differentiates 
PSCs to mimic their natural maturation during embryonic development in order to study the 
mechanisms directing these events.  We have genetically engineered mouse and human 
embryonic stem cells (ESCs) to express fluorescent protein reporters that enable us to visualize 
expression of critical genes during differentiation.  This allows us to have a rapid diagnostic 
readout on the effectiveness of experimental conditions and subsequently sort out individual 
cells of interest for further analysis.  The outcomes of my thesis work demonstrate that 
activation of the Wnt pathway coupled with inverse agonism of retinoic acid receptor (RAR)  
 Ryan Patrick Russell – University of Connecticut, 2018 
signaling is capable of inducing paraxial mesoderm, an intermediate cell type arising early in 
development and a key phase in the progression from PSCs to skeletal progenitor cells. Our 
studies reveal paraxial mesoderm induction is significantly more efficient from the “primed” or 
epiblast stem cell state compared to the “naïve” inner cell mass like state.  Further, inverse 
agonism of RARs during the formation of epiblast-like cells favors a paraxial mesoderm fate.   
Collectively, my thesis work has provided a more complete understanding of the molecular 
mechanisms prompting stem cell specification into paraxial mesoderm, as well as an earlier 
than appreciated role for RARs in epiblast cells where they potentially function as transcriptional 
repressors.   
  
 
 
 
 
 
 
 
 
 
 
 
 Retinoic Acid Receptor Signaling During Paraxial Mesoderm  
Differentiation of Pluripotent Stem Cells 
 
 
Ryan Patrick Russell 
 
 
B.S., University of Connecticut, 2008 
M.A., Central Connecticut State University, 2011 
 
 
 
 
 
 
A Dissertation 
Submitted in Partial Fulfillment of the 
Requirements for the Degree of  
Doctor of Philosophy 
at the 
University of Connecticut  
2018 
 
ii 
 
 
Copyright by 
Ryan Patrick Russell 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018 
 
iii 
 
APPROVAL PAGE 
 
Doctor of Philosophy Dissertation 
 
Retinoic Acid Receptor Signaling During Paraxial Mesoderm  
Differentiation of Pluripotent Stem Cells 
 
 
Presented by 
Ryan Patrick Russell, B.S., M.A. 
 
 
 
Major Advisor_________________________________________________________________ 
     Peter F. Maye 
 
Associate Advisor______________________________________________________________ 
     Anne Delany 
 
Associate Advisor______________________________________________________________ 
     Mina Mina 
 
 
 
 
 
 
 
 
University of Connecticut 
2018 
iv 
 
ACKNOWLEDGEMENTS 
 
 I would like to thank my thesis advisor, Dr. Peter Maye, for the continued guidance and 
support during the past years. I appreciate all your encouragement and advice during such an 
important period of my life, your mentorship extended well beyond science.  I would also like to 
note my sincere appreciation of my thesis committee members, Dr. Anne Delany and Dr. Mina 
Mina, two exceedingly perceptive individuals who are also outstanding scientists.  I cannot 
thank you both enough for all your help along the way.  I must also acknowledge the training 
and support received during my appointment to the T90 Training Grant, as well as the 
leadership of Dr. Mina and Dr. Jon Goldberg for providing such a rewarding opportunity for so 
many young scientists.   
 
 I would also like to thank UConn Health and the Biomedical Science Graduate Program, 
and especially Dr. Barbara Kream whose tremendous guidance began even before I applied to 
the program and continues to this day. Thank you to Dorothy Linnhoff, Stephanie Rauch, Carrie 
Norris and Dan Lis for their great work and dedication to the Biomedical Science students. Many 
thanks to the Skeletal Biology & Regeneration Faculty and fellow students.  Thank you to 
Annmarie Martin and Lisa Ramsdell for all their support.   
 
 Thank you to the Department of Reconstructive Sciences, especially Dr. David Rowe, 
Dr. Nat Dyment, Dr. Ivo Kalajzic, Dr. Mark Kronenberg and Yaling Liu whose support was 
invaluable.  Thank you to the Department of Orthopedic Surgery, especially Dr. Augustus 
Mazzocca, Dr. Robert Arciero, Dr. Mark Cote, Dr. Knut Beitzel, Dr. John Apostolakos and Mary 
Beth McCarthy.  Thank you to all the teachers who have made an impact along the way.  
 
v 
 
 Most importantly, I would like to acknowledge the unwavering support of my entire 
family.  I especially want to thank my parents, Patti and Kevin, I would not be in this position 
without all you have given me and all you continue to do.  To my brother Joe and his family, my 
grandparents Anne and Joe, all my aunts, uncles, cousins and friends; you have all been an 
important part of this journey and I am forever grateful.  Finally, my biggest thank you is saved 
for my wife, Kristen.  Thank you for all your love and support, your hard work, and for being 
such a great mom to Isla.  We are truly lucky to have you.  
 
 
 
 
For Kristen and Isla.  
All of my love, this work is dedicated to you. 
 
 
 
 
 
 
 
 
 
 
 
  
vi 
 
TABLE OF CONTENTS 
Copyright.......................................................................................................................................ii
Approval page..............................................................................................................................iii 
Acknowledgements......................................................................................................................iv 
List of Tables...............................................................................................................................viii 
List of Figures...............................................................................................................................ix 
 
Chapter 1: Introduction.................................................................................................................1 
 1.1 Stem Cells and Orthopaedic Regenerative Medicine…………………...…….….........2
 1.2 Stem Cells and Embryogenesis..................................................................................3 
 1.3 Stem Cell States.........................................................................................................4 
 1.4 Post-Implantation Embryonic Development................................................................6 
 1.5 Paraxial Mesoderm Specification and Maturation.......................................................8 
 1.6 Retinoic Acid Receptor Signaling..............................................................................10 
 1.7 Research Innovation..................................................................................................13 
 
Chapter 2: Specific Aims.............................................................................................................14 
 
Chapter 3: Inverse Agonism of Retinoic Acid Receptors Directs Epiblast Cells into the Paraxial 
  Mesoderm Lineage.........................................................................................................17 
 3.1 Introduction................................................................................................................20  
 3.2 Material and Methods................................................................................................23 
 3.3 Results.......................................................................................................................27 
 3.4 Discussion.................................................................................................................44 
 
 
vii 
 
Chapter 4: Differentiation of Human Embryonic Stem Cells into the  
 Paraxial Mesoderm Lineage............................................................................................52 
 4.1 Introduction................................................................................................................53  
 4.2 Materials and Methods..............................................................................................55 
 4.3 Results.......................................................................................................................59 
 4.4 Discussion.................................................................................................................65 
 
Chapter 5: Conclusions & Future Directions...............................................................................69 
 
References..................................................................................................................................74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
LIST OF TABLES 
 
 
Chapter 3 
Table 3.1: Mouse qPCR Primer Sequences................................................................................26  
 
Chapter 4 
Table 4.1: Human qPCR Primer Sequences...............................................................................58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ix 
 
LIST OF FIGURES 
 
Chapter 1 
Figure 1.1. Comparison of pluripotent stem cells derived from mouse and human embryos........5 
Figure 1.2. Comparison of mouse stem cell states.......................................................................6 
Figure 1.3. Paraxial mesoderm formation and segmentation........................................................8 
Figure 1.4. Retinoic acid receptor structure and signaling..........................................................12 
Chapter 3 
Figure 3.1. Paraxial mesoderm induction in a Tbx6 and Brachyury dual reporter mouse ESC 
 model...............................................................................................................................28 
Figure 3.2. Inverse agonism of RARs augments mesoderm induction.......................................31 
Figure 3.3. Conversion of mouse ESCs to epiblast state enhances paraxial mesoderm 
 differentiation...................................................................................................................34 
Figure 3.4. Distinct roles of RAR inverse agonist treatment in regulating paraxial mesoderm 
 formation and maturation.................................................................................................38 
Figure 3.5. Treatment of epiblast cells with RAR inverse agonist favors a paraxial mesoderm 
 fate...................................................................................................................................42 
Figure 3.6. Individual channel images for paraxial mesoderm induction in a Tbx6 and Brachyury 
 dual reporter mouse ESC model.....................................................................................49 
Figure 3.7. Individual channel images for inverse agonism of RARs augments mesoderm 
 induction..........................................................................................................................50 
 
x 
 
Chapter 4 
Figure 4.1. Generation of dual reporter H9 ESC line...................................................................58 
Figure 4.2. Retinoic Acid Inverse Agonism Increases TBX6 Reporter Expression.....................60 
Figure 4.3. TBX6 Reporter-Positive Cells Identify Paraxial Mesoderm from Human ESCs........62 
Figure 4.4.  Stem Cell State Affects Differentiation and Reporter Expression............................64 
Figure 4.5. TBX6 Reporter-Positive Cells are Highly Enriched for CXCR4.................................66 
 
1 
 
CHAPTER 1 
 
 
 
 
 
 
 
INTRODUCTION 
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INTRODUCTION 
 
1.1 Stem Cells and Orthopaedic Regenerative Medicine 
 Regeneration of bone tissue lost due to injury or disease remains an unmet clinical 
challenge1.  Critical-size bone defects, known as non-unions, are predominantly treated 
via autologous bone grafts, often harvested from the patient’s iliac crest.  Limitations 
inherent to the autograft approach, including increased risk of infection, poor integration, 
chronic pain, donor site morbidity and limited tissue supply, have propelled the search for 
alternative interventions.  Use of synthetic bone substitutes and administration of 
recombinant growth factors such as bone morphogenetic proteins (BMPs) have also been 
explored but are also limited by high costs and adverse side effects. Various cell-based 
approaches for repair augmentation have been gaining traction, notably bone marrow-
derived mesenchymal stem cells (MSCs)2.  However, inconsistent outcomes and the 
overall variability of this adult stem cell population has thus far curtailed the clinical impact 
of MSCs on bone regeneration3. Therefore, reliable cell-based therapeutic options, 
without the need for high doses of growth factors and potential off-target effects, will 
continue to be explored.  Embryonic stem cells (ESCs) and induced pluripotent stem cells 
(iPSCs) provide a valuable model for studying cell maturation and lineage differentiation 
due to their pluripotent nature and may soon be broadly used for treating orthopedic 
injuries4,5.   
  
The impact of stem cell technologies on recent advances in basic science 
research and emerging regenerative medicine therapies has been tremendous, however 
the prospect of fully harnessing the pluripotent and self-renewal capabilities of embryonic 
or induced pluripotent stem cells may be as onerous as it is appealing.  With over 200 
distinct human cell types catalogued, preventing a stem cell from becoming any particular 
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cell type may be just as important, and as difficult, as generating the cell type of interest 
from a given differentiation protocol.  Likewise, dynamic processes such as establishment 
of the morphogenetic gradients responsible for directing cell migration and lineage 
specification in the developing embryo are not easily recapitulated in vitro6.  Similar events 
initiate the healing response within the tissue microenvironment surrounding a fracture 
site by recruiting adult stem cells which then differentiate to replace damaged cells. 
Consequently, understanding the mechanics of stem cell specification and differentiation 
is paramount for developing cell-based regenerative medicine strategies.  In terms of the 
skeletal stem cell biology field, a more comprehensive understanding of how to direct 
pluripotent stem cells (PSC)s into mature, functional skeletal cell types remains a 
necessity and will be an essential advancement in the realm of orthopaedic translational 
medicine.  
 
 We have focused on a differentiation strategy that is more reflective of early 
embryonic development. This approach follows a stepwise, embryonic differentiation 
program to derive cells of the axial skeletal lineage via paraxial mesoderm and sclerotome 
intermediates to generate a functional and sustainable therapeutic cell source.  Our 
current focus is on optimizing the generation of cells characteristic of paraxial mesoderm 
through a more precise control of embryonic signaling mechanisms in order to improve 
subsequent differentiation into the somitic stage and eventual derivation of skeletal cell 
progenitors 
 
1.2 Stem Cells and Embryogenesis 
 Mammalian embryogenesis is initiated by the formation of a diploid, single-celled 
zygote following egg fertilization.  Several rounds of mitotic cell divisions via rotational 
holoblastic cleavage create a dense sphere of cells called the morula7.  The blastocyst 
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stage initiates as cells form a hollow sphere surrounding an inner fluid-filled cavity known 
as the blastocoel.  The first embryonic cell specification events occur at this stage as cell 
of the outer layer begin to form the trophoblast, which will contribute to forming extra-
embryonic tissues, including the placenta8,9.  Cells on the interior of the blastocyst gather 
to form the inner cell mass which eventually gives rise to the definitive fetal structures.  
This early delineation of cell fate was critical for mammalian evolution and is a defining 
juncture for the origination of embryonic stem cell research.  The characteristic abilities of 
ESCs to proliferate continuously, maintain a stable karyotype, and differentiate into any 
cell type result from their derivation from the inner cell mass at the pre-implantation 
blastocyst stage.  Significant advances in culturing techniques developed on mouse ESCs 
led to the eventual generation of human ESC lines, only two decades prior to this text10,11.  
The blastocysts used for derivation of these lines were produced for clinical conception 
purposes via in vitro fertilization. 
 
1.3 Stem Cell States 
   It is a fundamental, yet important distinction that not all stem cells are the same, 
especially when considering the multitude of stem cell lines derived and characterized 
from mammalian sources other than mouse or human.  Similarly, mouse and human 
ESCs exist in alternative ‘states’, due to differences in the timing of embryonic 
development between the two species12 (Fig. 1.1).  Mouse ESCs are isolated from the 
inner cell mass and are thus able to be maintained in a state of naïve pluripotency, which 
refers to their ability to contribute to all adult tissues including the gametes11.  Because of 
the extended culture duration required between blastocyst isolation and emergence of 
stable human ESCs in vitro, it is understood that they more closely resemble the 
pluripotency state of post-implantation cells of the epiblast.  The flat, cobble-stoned  
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Figure 1.1. Comparison of pluripotent stem cells derived from mouse and human 
embryos.  Differences in timing of in vivo mouse and human development and the 
derivation of pluripotent cell lines in vitro.  The extended culture duration required for 
obtaining human embryonic stem cell outgrowth causes these cells to grow to the 
equivalency of mouse EpiSCs, which are derived from the post-implantation embryo12. 
 
 appearance of human ESCs and the mound-like morphology of mouse ESCs are 
characteristic of their respective pluripotency states (Fig 1.2). 
 
The identification of defined culture conditions via inhibition of ERK signaling in 
combination with inhibition of glycogen synthases kinase 3 (GSK3) using two small 
molecule inhibitors, termed ‘2i’, vastly improved the derivation efficiency of naïve stem 
cells by blocking differentiation cues normally promoted during development.  In addition,  
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stem cells may be isolated from developmental stages other than the blastocyst, notably 
from the mouse post-implantation late epiblast.  The resulting cells, termed EpiSCs, are 
isolated from the post-implantation embryo and can also be obtained in culture by treating 
ESCs with Fibroblast Growth Factor 2 and Activin A13.  Mouse EpiSCs exhibit a much 
flatter appearance in comparison to naïve ESCs and are thus more analogous to human 
ESCs in terms of both their morphological and pluripotent states14 (Fig 1.2). 
 
1.4 Post-Implantation Embryonic Development 
Subsequent stages of vertebrate embryo development are initiated as stem cells of the 
blastocyst inner cell mass segregate to form epiblast and hypoblast layers, with epiblast 
cells eventually forming the embryo proper15.  Gastrulation then initiates the migration of  
epiblast cells through the primitive streak during which differential cell fate determination 
organizes the three embryonic germ layers: ectoderm, mesoderm and endoderm.  The 
vertebrate embryo develops and matures in an anterior-to-posterior manner, meaning the 
most immature cells are found in the posterior, or caudal, region where tailbud elongation 
occurs.  The caudal epiblast contains a progenitor population that self-renews within the 
 
 
Figure 1.2. Comparison of mouse stem cell states.  Naïve ESCs (left) and primed 
EpiSCs (right) represent separate morphological appearances and different pluripotency 
states13. 
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tailbud to ensure that a sufficient supply of cells is added to the developing germ layers as 
embryo elongation progresses16.  Concurrently, the newly forming mesoderm is further 
divided into specific subtypes, including the presomitic, intermediate and lateral plate 
mesoderm regions, dependent on local morphogen signaling gradients17. 
 
 The skeleton is derived from three distinct embryonic lineages. Craniofacial 
structures are mostly derived from the cranial neural crest along with some contribution 
from the anterior paraxial mesoderm18,19. The appendicular skeleton is derived from lateral 
plate mesoderm20, while the axial skeleton is largely derived from paraxial mesoderm with 
the exception of the intervertebral disc, which in mammals is derived from notochord 
cells21–23.  Newly formed paraxial mesoderm, also called presomitic or unsegmented 
mesoderm, is a multipotent embryonic tissue that is formed during vertebrate gastrulation 
and is sustained through proliferation and migration of cells from the caudal progenitor 
zone of the tailbud as embryogenesis progresses24. Paraxial mesoderm (PM) cells are 
mesenchymal and motile and express the early mesodermal marker Brachyury (T), as 
well as T-Box6 (TBX6), a gene essential for PM formation and prevention of neural cell 
fate via antagonism of SOX2 expression25.  PM cells gradually shift from a posterior to  
anterior fate as the vertebrate axis extends caudally. The presomitic mesoderm begins to 
epithelialize and becomes segmented; progressively forming paired somites flanking the 
neural tube (Fig.1.3). Individual somites undergo further specification to form cellular 
compartments known as the sclerotome, syndetome, myotome and dermatome, which 
contain the precursors for cartilage and bone, tendon, skeletal muscle and skin, 
respectively.   
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Figure 1.3. Paraxial mesoderm formation and segmentation. (Left) Paraxial 
mesoderm forms alongside the vertebrate neural tube and matures into somites. (Right) 
View of the elongating embryonic anteroposterior axis showing the presomitic mesoderm 
progenitor pool extending anteriorly from the tailbud region. Cells reaching the 
‘determination front’ (blue) are primed for epithelialization and somite segmentation26,27. 
 
 
 
1.5 Paraxial Mesoderm Specification and Maturation 
Pluripotent stem cells are a valuable model for studying development and disease 
and may be the ideal cell source for generating therapeutic progenitors. In terms of 
skeletal biology and orthopedic applications, we have been interested in understanding 
how to differentiate embryonic stem cells (ESCs) into paraxial mesoderm. The paraxial 
mesoderm is an embryonic tissue that gives rise to all of the cartilage, bone, skeletal 
muscle, and tendons that make-up the axial skeleton.  Because of it embryonic 
importance and vast potential, there has been an increasing focus on studying the 
mechanisms underlying paraxial mesoderm formation. Two transcription factors, T-box 6 
(Tbx6) and Mesogenin (Msgn) are pivotal regulators in the transition of caudal epiblast 
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cells into unsegmented paraxial mesoderm, which is also known as presomitic mesoderm 
(PSM).  Tbx6 represses Sox2 expression to direct caudal epiblast cells into the paraxial 
mesoderm lineage 28,29.  The requirement for proper Tbx6 expression was demonstrated 
in mouse knockouts where ectopic neural tubes formed at the expense of paraxial 
mesoderm formation in the absence of Tbx630. Msgn regulates progenitor cell migration 
out of the tailbud and initiates their specification into PSM, and is therefore critical for 
balancing paraxial mesoderm specification and maintenance of the caudal progenitor 
population 31,32. Thus, proper embryo elongation and axis patterning are maintained 
through precise control of paraxial mesoderm differentiation and maturation coordinated 
by the expression of Tbx6 and Msgn.  
 
 Wnt and FGF signaling pathways also have essential roles in the lineage 
specification and outgrowth of axial progenitor cells. A phenotype similar to loss of Tbx6 in 
which epiblast cells are forced into the neural ectoderm fate occurs at the expense of 
paraxial mesoderm formation in both Wnt3a-null33 and Lef1/Tcf1 double mutant mice34.  
In fact, mesoderm formation in general is dependent upon canonical Wnt signaling as 
demonstrated by Wnt3, β-Catenin, and LRP5/LRP635–37 knockout studies, showing that 
Wnt pathway stimulation is critical for differentiation into the mesoderm lineage.  While 
Wnt signaling will induce mesoderm, more robust pathway activation via differentiation 
with Wnt3a ligand and/or GSK3β antagonists promotes formation of paraxial mesoderm 
over other mesoderm types38–42.  FGF signaling regulates several critical processes during 
embryonic development including germ layer formation during gastrulation and the 
specification and maintenance of the tailbud progenitor population43,44.  Mesoderm 
formation is initiated by FGF signaling in epiblast cells which triggers  migration through 
the primitive streak15,45,46.  Embryonic knockouts of Fgf4, Fgf8, Fgfr1, or Fgfr2 are all early 
embryonic lethal 47–50,  primarily due to failure of mesoderm formation and severe caudal 
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truncations caused by absence of the migratory and self-renewal cues supplied by the 
FGF signaling pathway.  
 
 The somitogenesis phase follows paraxial mesoderm formation, as somite pairs 
form at the anterior-most region of the presomitic mesoderm.  Maturing PSM cells 
undergo cyclical epithelialization creating the segmental border of each somite.  This 
periodic segmentation occurs under the control of two important transcription factors, 
Mesp2 and Ripply2, whose expression controls the size and organization of each somite 
pair51,52.  Mesp2 and Ripply2 establish the anterior boundary of the presomitic mesoderm 
by acting as negative regulators of Tbx6 expression. In the anterior PSM,Tbx6 in 
conjunction with Notch signaling negatively regulates its own expression by inducing 
Mesp2 expression which in turn activates Ripply2 expression53,54. Mesp2 and Ripply2 
cause Tbx6 degradation, while Ripply2 also downregulates Mesp2 expression to complete 
somite patterning 55,56.  Perhaps the most important modulator of the eventual maturation 
and segmentation of the PSM is the increasing concentration of retinoic acid affecting cell 
fate in this region of the embryo.   
 
1.6 Retinoic Acid Receptor Signaling 
 Retinoic Acid Receptors (RARα,β,γ) function as transcription factors that 
participate in numerous developmental and disease processes. Considerable attention 
has been given to how retinoic acid (RA) binding to RARs regulates their transcriptional 
function, however much less is understood about how RARs function in the absence of 
RA. RA signaling is mediated by nuclear RARs that complex with retinoid X receptors 
(RXRs) and act as transcription factors that associate with various coactivator or 
corepressor complexes to regulate gene expression.  The RAR-RXR dimers bind to 
hexameric direct nucleotide sequence repeats known as RA response elements (RAREs) 
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within regulatory regions of RA-responsive genes. Generally, absence of RA ligand leads 
to recruitment of repressive transcriptional cofactors, while RA-RAR binding typically 
activates target gene transcription through recruitment of co-activators. However, this 
mechanism is reversed for certain genes, including Fgf8 and others involved in cell 
pluripotency and proliferation, which are repressed as a result of RA-RAR binding57,58. 
This modality underscores the primary role of RA ligand in triggering differentiation via 
activation of cell-type specific genes through RARs, while simultaneously suppressing 
transcription of pluripotency-related genes, also through RARs. The pleiotropic effects of 
RA may be due to interaction of separate RAR subtypes or isoforms with the opposing 
target gene types.   
 
Animal models deficient in RA due to loss of genes required for synthesis of RA 
from vitamin A, including Raldh2, exhibit ectopic, anterior Fgf8 expression leading to 
expansion of the caudal progenitor population and disruption of somitogenesis59.  
Conversely, animals lacking Cyp26a1, which encodes an RA-degrading enzyme, suffer 
premature progenitor differentiation leading to an anteriorization of cell fate and caudal 
truncation defects60.  Also, a recent epigenetic study demonstrated that RA directly 
represses Fgf8 expression by recruiting polycomb complexes and triggering histone 
modifications near its upstream RARE leading to a repressive chromatin state61. 
 
Genes located on three separate chromosomes encode three distinct human RAR 
subtypes (α, β, γ), and each subtype has multiple isoforms due to alternative splicing.  
The DNA binding and ligand binding domains, denoted as regions C and E, respectively, 
are highly conserved between subtypes and throughout evolution (Fig 1.4). The A/B 
region located within the N-terminal domain varies widely between subtypes and between  
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subtype isoforms but plays a key role in regulating RA target gene transcription.  
Interestingly, the A/B region of RAR proteins contains a ligand-independent transcription 
activating function (AF-1), and a semi-conserved proline-rich motif of the B region 
contains phosphorylation sites which may influence DNA binding, co-regulator 
interactions, or degradation64.  The ligand-independent activity of RARs, and the fact that 
the AF-1 domain is found in a region of high variance between subtypes, is intriguing and 
reinforces the rationale behind our belief that RARγ signaling is of particular importance 
for specification of paraxial mesoderm, even in a region of the embryo, and likewise in our 
 
 
Figure 1.4. Retinoic Acid Receptor Structure and Signaling. (A) Basic structure of 
retinoic acid receptors. Sequence variations in the A/B region delineate the alpha, beta 
and gamma subtypes, while other domains are highly conserved62. (B) RA ligand 
binding to RARs recruits co-activator binding to activate transcription of certain target 
genes.  Co-repressor binding in the absence of ligand is also an important mechanism 
for transcriptional repression in the absence on RA ligand63.  
13 
 
cell culture system, where RA ligand is absent. Finally, regarding the axial skeleton 
beyond the presomitic mesoderm phase, RAR signaling plays critical roles in 
somitogenesis, chondroprogenitor specification, and postnatal bone maintenance63,65,66.  
 
1.7 Research Innovation 
The innovation of this thesis lies in our overall research approach, which has focused on a 
specific skeletal lineage combined with the utility of fluorescent reporter stem cell lines 
which help expedite our progress towards understanding the complexities inherent to 
stem cell differentiation. Few established differentiation protocols focus on transitioning 
between distinct stages of cell development, and even fewer emphasize the role of 
retinoic acid receptor signaling during stem cell differentiation. We demonstrate the 
importance of the stem cell state on mesoderm induction and the influence early cell fate 
decisions have on downstream differentiation potential.  This work has added to the 
fundamental knowledge of skeletal stem cell derivation and established an early 
developmental roadmap for generating therapeutically relevant skeletal progenitor cells. 
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SPECIFIC AIMS 
 
 Treatment of severe musculoskeletal injuries is currently limited to surgical 
intervention and reliance on natural healing processes during recovery, which are not 
always sufficient to repair critical tissue defects. Various cell-based approaches for repair 
augmentation have been gaining traction, however a reliable cell therapy approach, 
without the need for concurrent application of growth factors carrying potential for off-
target effects, has not been realized.   
  
The long-term goal of our research is to develop a cell therapy approach to 
regenerate bone tissue without the need for administration of high-dose growth factors, 
which can cause repair to go haywire, leading to poor quality, ectopic bone formation.  
Our strategy utilizes pluripotent stem cells, which are capable of forming all cell types 
within the body, to specifically generate forerunners of osteoblasts, the cells responsible 
for creation of new bone.   
  
The skeleton is derived from three distinct embryonic precursors, neural crest, 
lateral plate mesoderm, and paraxial mesoderm. Out of these three lineages, we have 
been compelled to investigate paraxial mesoderm formation because paraxial mesoderm 
entirely contributes to the cartilage, bone, tendon, and muscle that comprise the axial 
skeleton. Thus, the benefit of investigating mechanisms underlying paraxial mesoderm 
formation is that it may lead to discovery of novel methods for generating a variety of 
clinically applicable skeletal cell types.   
  
To approach these studies using an in vitro culture system, we have genetically 
engineered mouse and human pluripotent stem cell lines that produce fluorescent proteins 
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of key gene markers of paraxial mesoderm formation. This allows us to visualize cellular 
differentiation in real time and provides an ability to have a rapid diagnostic readout on the 
effectiveness of our experimental conditions.  
 
 Our work has led us to become very interested in the function of Retinoic Acid 
Receptors (RAR) in the absence of Retinoic Acid (RA) during the early stages of 
embryogenesis leading up to the formation of paraxial mesoderm.  Our preliminary studies 
show that treatment with AGN193109, an RAR inverse agonist, along with canonical Wnt 
pathway and fibroblast growth factor (FGF) pathway stimulation promotes the formation of 
paraxial mesoderm.   
  
The aims of this thesis will further investigate how AGN193109 promotes paraxial 
mesoderm formation by: (1) Determining what cellular stage(s) do RARs function in the 
absence of RA to promote paraxial mesoderm formation; and (2) Identifying which RARs 
function in the absence of RA to promote paraxial mesoderm formation.  
 
Our central hypothesis: RARs function in the absence of RA during the 
transition from caudal epiblast to presomitic mesoderm to promote paraxial 
mesoderm formation from pluripotent stem cells.  
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INVERSE AGONISM OF RETINOIC ACID RECEPTORS DIRECTS EPIBLAST CELLS 
INTO THE PARAXIAL MESODERM LINEAGE 
 
Ryan P. Russell, Yu Fu, Yaling Liu, Peter Maye 
Department of Reconstructive Sciences 
School of Dental Medicine  
University of Connecticut Health Center 
United States 
 
This work has been previously published as an open access article in the journal:  
Stem Cell Research 
DOI: 10.1016/j.scr.2018.05.016 
 
Abstract 
We have investigated the differentiation of paraxial mesoderm from mouse embryonic 
stem cells utilizing a Tbx6-EYFP/Brachyury (T)-Cherry dual reporter system. 
Differentiation from the mouse ESC state directly into mesoderm via Wnt pathway 
activation was low, but augmented by treatment with AGN193109, a pan-retinoic acid 
receptor inverse agonist. After five days of differentiation, T+ cells increased from 12.2% to 
18.8%, Tbx6+ cells increased from 5.8% to 12.7%, and T+/Tbx6+ cells increased from 
2.4% to 13.1%. The synergism of AGN193109 with Wnt3a/CHIR99021 was further 
substantiated by the increased expression of paraxial mesoderm gene markers Tbx6, 
19 
 
Msgn1, Meox1, and Hoxb1. Separate to inverse agonist treatment, when mouse ESCs 
were indirectly differentiated into mesoderm via a transient epiblast step the efficiency of 
paraxial mesoderm formation markedly increased.   Tbx6+ cells represented 65-75% of 
the total cell population after just 3 days of differentiation and the expression of paraxial 
mesoderm marker genes Tbx6 and Msgn increased over 100-fold and 300-fold, 
respectively.   The further evaluation of AGN193109 treatment on the indirect 
differentiation protocol suggested that RARs have two distinct roles.   First, AGN193109 
treatment at the epiblast step and mesoderm step promoted paraxial mesoderm formation 
over other mesoderm and endoderm lineage types. Second, continued treatment during 
mesoderm formation revealed its ability to repress the maturation of presomitic mesoderm 
into somitic paraxial mesoderm.   Thus, the continuous treatment of AGN193109 during 
epiblast and mesoderm differentiation steps yielded a culture where ~90% of the cells 
were Tbx6+.   The surprisingly early effect of inverse agonist treatment at the epiblast step 
of differentiation led us to further examine the effect of AGN193109 treatment during an 
extended epiblast differentiation protocol. Interestingly, while inverse agonist treatment 
had no impact on the conversion of ESCs into epiblast cells based on the expression of 
Rex1, Fgf5, and pluripotency marker genes Oct4, Nanog, and Sox2, after three days of 
differentiation in the presence of AGN193109 caudal epiblast and early paraxial 
mesoderm marker genes, T, Cyp26a1, Fgf8, Tbx6 and Msgn were all highly up-regulated.   
Collectively, our studies reveal an earlier than appreciated role for RARs in epiblast cells 
and the modulation of their function via inverse agonist treatment can promote their 
differentiation into the paraxial mesoderm lineage.    
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3.1. Introduction 
The differentiation of pluripotent stem cells can be used as a valuable approach to 
study development, disease and obtain therapeutic progenitor cells. Our interest in 
skeletal biology has motivated us to learn how to differentiate embryonic stem cells 
(ESCs) into paraxial mesoderm. The paraxial mesoderm is a highly desirable cell 
population to generate because it is the precursor that gives rise to all of the cartilage, 
bone, skeletal muscle, and tendons that make-up the axial skeleton.  
 
An increasing body of work has provided crucial insight into the mechanisms that 
instruct paraxial mesoderm formation. Two transcription factors, T-box 6 (Tbx6) and 
Mesogenin (Msgn) are pivotal regulators in the transition of caudal epiblast cells into 
unsegmented paraxial mesoderm, which is also known as presomitic mesoderm.  
Targeted loss of Tbx6 in mice resulted in the formation of ectopic neural tubes at the 
expense of paraxial mesoderm formation 30. Tbx6 represses Sox2 expression to direct 
caudal epiblast cells into the paraxial mesoderm lineage 28,29. Msgn orchestrates the 
differentiation and migration of progenitor cells exiting the tailbud which form the 
presomitic mesoderm, and is therefore critical for balancing paraxial mesoderm 
specification and maintenance of the caudal progenitor population 31,32. Together, Tbx6 
and Msgn control the differentiation and maturation of paraxial mesoderm required for 
proper embryo elongation. 
 
Wnt and FGF signaling pathways have essential roles in the lineage specification 
and outgrowth of axial progenitor cells. Targeted loss of Wnt3a 33 and Lef1/Tcf1 double 
mutants 34 resulted in a phenotype similar to loss of Tbx6 in that broader contribution of 
epiblast cells into the neural ectoderm fate at the cost of forming paraxial mesoderm. With 
that in mind, there is an overwhelming amount of genetic and biochemical data showing 
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that canonical Wnt signaling plays a major role in mesoderm formation. Gene targeting 
studies in mice have shown how several members of the Wnt pathway are required for 
mesoderm formation including, Wnt3, β-Catenin, and LRP5/LRP6 double mutants 35–37. 
During ESC differentiation, Wnt3a and GSK3β antagonists are commonly used to induce 
mesoderm formation with higher levels of canonical Wnt activity promoting the formation 
of paraxial mesoderm 38–42. FGF signaling is indispensable during embryogenesis, as 
knockouts of Fgf4, Fgf8, Fgfr1, or Fgfr2 are all early embryonic lethal 47–50, and dominant 
negative mutants display disruption of gastrulation cell movements, lack of mesoderm 
specification, and severe caudal truncation 43,44. FGF signaling in epiblast cells promotes 
migration through the primitive streak to initiate mesoderm formation and patterning, and a 
high FGF concentration persists in the tailbud to maintain the pluripotency and 
proliferation of cells contributing to the posterior paraxial mesoderm 15,45,46. Subsequent to 
presomitic mesoderm formation, a cyclical process of maturation occurs that involves 
periodic segmentation to form paired somites. Two important transcription factors Mesp2 
and Ripply2 are critical in forming the segmental border at the anterior most region of the 
presomitic mesoderm thereby controlling the size and organization of each somite 51,52. 
Functioning as negative regulators, Mesp2 and Ripply2 establish the anterior boundary of 
Tbx6, and therefore mark the extent of the presomitic mesoderm domain. A negative 
feedback loop exists in the PSM wherein Tbx6, along with Notch signaling, induces 
Mesp2 expression which in turn induces Ripply2 expression 53,54. Mesp2 and Ripply2 
cause Tbx6 degradation, while Ripply2 also downregulates Mesp2 expression to complete 
somite patterning 55,56.  
 
The maturation of paraxial mesoderm is also highly regulated by Retinoic Acid 
(RA) signaling. At the caudal end of the developing embryo, Cyp26a1, a gene that 
encodes for an enzyme which breaks-down retinoic acid, is expressed thereby specifying 
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a region absent of RA signaling 67. Targeted loss of Cyp26a1 results in severe caudal 
truncation, which mimics defects caused by teratogenic levels of RA 60,68. Examination of 
Wnt3a and FGF8 expression in Cyp26a1 mutants, genes normally expressed at the 
caudal end and important for driving axial outgrowth were down-regulated. However, as 
the anterior most region of presomitic mesoderm distances itself from the caudal end 
where Cyp26a1 is expressed, levels of RA signaling increase in conjunction with the 
formation of somites and Meox1 expression 69,70. Aldh1a2, a gene that encodes for an 
enzyme responsible for RA synthesis is highly expressed in the somites and is necessary 
for proper somite development 58. Interestingly, of the three Retinoic Acid Receptors 
(RARα,β,γ), RARγ and RARβ are expressed in distinct zones that correspond with the 
caudal tail and trunk region, zones retaining low and high retinoic acid signaling, 
respectively.  
 
In this study, we have undertaken efforts to direct mouse ESCs into paraxial 
mesoderm. Our work has led us to become very interested in the role of RARs in this 
process. Here we present evidence that inverse agonism of RARs via treatment of 
AGN193109, a pan-RAR inverse agonist in epiblast cells and nascent mesoderm 
promotes their differentiation into paraxial mesoderm. 
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3.2. Materials and Methods 
 
3.2.1. Cell Culture 
Mouse ESCs were maintained on 0.1% gelatin coated tissue culture dishes 
(Thermo Scientific) and grown in serum free media containing a 1:1 mixture of DMEM/F12 
and Neurobasal medium (Life Technologies), N2 and B27 supplements, 0.05% BSA, 
100U/ml penicillin, 100µg/ml streptomycin, 1.5x10-4 M monothioglycerol, 3uM CHIR99021 
(Stemgent), 1uM PD0325901 (Cayman Chemical), and 10ng/ml LIF (Millipore)71,72. For 
differentiation, mouse ESCs were seeded on tissue culture dishes coated with Geltrex 
(Gibco) and grown for a minimum of 24 hours in maintenance media.  For differentiation, 
cells were grown in a 3:1 mixture of IMDM and Ham’s F12 (Life Technologies) N2, B27 
without vitamin A, 0.05% BSA, 100U/ml penicillin, 100µg/ml streptomycin, 1.5x10-4 M 
monothioglycerol, and 0.5mM ascorbic acid. For mesoderm differentiation, 50ng/ml Wnt3a 
(PeproTech), 3uM CHIR99021 (Stemgent), 1uM AGN193109 (Santa Cruz Biotechnology), 
10ng/mL FGF2 and 100ng/ml Noggin (PeproTech) were added in different combinations. 
Epiblast induction was carried out in differentiation media containing 10ng/mL FGF2 and 
10ng/mL Activin A (R&D Systems), with or without 1uM AGN193109 for the indicated 
durations. Note: While initial experiments used both Wnt3a and CHIR99021, it was 
determined that the potency of this combination was negligible to that of CHIR99021 
alone. Subsequent experiments utilized CHIR99021 without the addition of Wnt3a. 
 
3.2.2. Generation of Fluorescent Reporter ESC Lines 
For the creation of Tbx6-EYFP/T-Cherry dual reporter mouse ESCs, a BAC clone 
CTD-2379F21 (Children’s Hospital Oakland Research Institute) containing the Brachyury 
gene was engineered with a Cherry fluorescent reporter gene using bacterial 
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recombination strategies as previously described73. In brief, a homology arm was PCR 
amplified from the BAC clone using Pfx DNA polymerase (Life Technologies) with primers  
5’-CTCTGCGGCCGCACTGAATTTCGGTCCCCAGAGA-3’ (sense),  
5’-CTCTGGATCCGAAGCCCAGACTCGCTACCTGA-3’ (antisense). The DNA fragment 
was cloned into the Not1-BamH1 site of pLD53.SC2-Cherry and Rec A was used to 
integrate the reporter into the BAC clone. The BAC clone was then retrofitted with 
puromycin resistance through Cre/LoxP recombination by co-electroporating pCTP, which 
expresses Cre recombinase and pUni, which contains an EF1α-puromycin resistance 
gene and a LoxP site into CTD-2379F21 competent bacteria. Purified BAC was 
transfected into Tbx6-H2B-EYFP ESCs (generously provided by Sonja Nowotschin and 
Katerina Hadjantonakis 74) using Lipofectamine 2000 (Life Technologies) and clones were 
enriched by puromycin selection and screened for the transgene by PCR genotyping 
using:  
5’-CTCTGCGGCCGCACTGAATTTCGGTCCCCAGAGA-3’ (sense) and  
5’-GCACCTTGAAGCGCATGAACTCCTTGATGA-3 (antisense). Reporter expression was 
observed in individual clones by in vitro differentiation to select for optimal expressing cell 
lines.  
 
3.2.3. FACS Sorting and Analyses 
ESCs were washed twice with cold PBS then digested using Accutase (StemCell 
Technologies) and centrifuged at 300g for 5 minutes. Cells were then resuspended in FACS 
staining buffer (PBS, 0.5% BSA, 2 mM EDTA, pH 7.2) and sorted for Tbx6-EYFP and T-
Cherry reporter expression. FACS sorting was carried out using a FacsAria II  
For FACS analyses, cells were harvested in the same fashion as sorting, but were analyzed 
on a Becton-Dickinson LSRII flow cytometer. FACS sorting and analyses were carried out 
at the UCHC Flow Cytometry Core. 
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3.2.4. RNA Purification and Quantitative RT-PCR  
RNA purification was carried out using the NucleoSpin RNA kit (Macherey-Nagel) according 
to manufacturer’s recommendations, including a genomic DNA digestion step. cDNA was 
prepared from 500 ng of RNA/sample using the ProtoScript II Reverse Transcriptase (New 
England BioLabs). QPCR was carried out using SybrGreen PCR Master Mix (BioRad) in an 
ABI 7900HT (Applied Biosystems). PCR primer sequences for gene expression analyses 
were designed using qPrimer Depot 75 (http://mouseprimerdepot.nci.nih.gov/), a database 
of optimized primers for RefSeq genes.  
 
3.2.5. Microscopy and Imaging 
Cells in culture were imaged using a Zeiss Observer Z.1 inverted microscope. 
Fluorescence was detected using the following filter sets (Chroma Technology): 
HQ 500/20, HQ535/30, Q515lp, for EYFP, and HQ577/20x, HQ640/40m, Q595lp 
for Cherry fluorescent protein. Images were captured using an Axiocam MRc 
digital camera and Zen software (Zeiss). 
 
3.2.6. Statistical Analyses 
Quantitative realtime PCR data are presented as mean ± standard error of the mean 
(SEM). Differential gene expression between groups was statistically analyzed with 
a t test (CFX Manager Software 3.1; Bio-Rad Laboratories, Munich, Germany). 
Differences were considered statistically significant at P < .05 (*). 
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Table 3.1. Mouse QPCR Primers 
Gene 
Symbol 
Sense (Forward) Antisense (Reverse) Species 
Gapdh 5’-CGTCCCGTAGACAAAATGGT-3’ 5’-TTGATGGCAACAATCTCCAC-3’ Mouse 
Tbx6 5’-TGACAGCCTACCAGAACCCT-3’ 5’-CCCGAAGTTTCCTCTTCACA-3’ Mouse 
Msgn1 5’-AACCTGGGTGAGACCTTCCT-3’ 5’-TCCGCATCCTGAGTTTCTCT-3’ Mouse 
Hoxb1 5’-TTCGACTGGATGAAGGTCAA-3’ 5’-GGTGAAGTTTGTGCGGAGAC-3’ Mouse 
Meox1 5’-GCCAATGAGACGGAGAAGAA-3’ 5’- TTGGTGAAGGCTGTCCTCTC-3’ Mouse 
Sox2 5’-ACAAGAGAATTGGGAGGGGT-3’ 5’-AAGCGTTAATTTGGATGGGA-3’ Mouse 
T 5’-GTCTAGCCTCGGAGTGCCT-3’ 5’-CCATTGCTCACAGACCAGAG-3’ Mouse 
Fgf8 5’-GCTCATTGTGGAGACCGATA-3’ 5’- AATACGCAGTCCTTGCCTTT-3’ Mouse 
Wnt3a 5’-ACTACGTGGAGATCATGCCC-3’ 5’- GGTGGCTTTGTCCAGAACAG-3’ Mouse 
Mesp2 5’-TGGACACAATCCACTGAACC-3’ 5’-GGCTGTAGTCTCTGGCATGA-3’ Mouse 
Ripply2 5’-ATGGATACCACCGAGAGCGCCGAGA-3’ 5’-GGTACCCGGGCTGCGCGGAC-3’ Mouse 
Mixl1 5’-CGACAGACCATGTACCCAGA-3’ 5’-CCTTGAGGATAAGGGCTGAA-3’ Mouse 
Eomes 5’-GGCCTACCAAAACACGGATA-3’ 5’-GACCTCCAGGGACAATCTGA-3’ Mouse 
Lhx1 5’-TGTAAATGCAACCTGACCGA-3’ 5’-AACCAGATCGCTTGGAGAGA-3’ Mouse 
Fgf5 5’-GCTGTGTCTCAGGGGATTGT-3’ 5’- ACAGTCATCCGTAAATTTGGC-3’ Mouse 
Nanog 5’-AAGTACCTCAGCCTCCAGCA-3’ 5’-GTGCTGAGCCCTTCTGAATC-3’ Mouse 
Oct4 5’-AGAGGGAACCTCCTCTGAGC-3’ 5’-TTCTAGCTCCTTCTGCAGGG-3’ Mouse 
Cyp26a1 5’-GCAGGAAATACGGCTTCATC-3’ 5’-ATCACCTTCTTTCGCTGCTT-3’ Mouse 
Rex1 5’-TGAAAGTGAGATTAGCCCCGAG-3’ 5’-GTCCCATCCCCTTCAATAGCAC-3’ Mouse 
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3.3. Results 
 
3.3.1. Examination of Paraxial Mesoderm Induction in a Dual Reporter Mouse ESC 
Line  
To investigate the process of paraxial mesoderm formation from mouse ESCs, we 
obtained a T-box 6-H2B-EYFP (Tbx6-EYFP, green) knock-in ESC reporter line74 and 
introduced a Brachyury-Cherry BAC reporter (T-Cherry, red) into this cell line to generate 
dual reporter T-Cherry/Tbx6-EYFP ESCs (Fig.3.1A). During embryogenesis, Brachyury is 
transiently, but broadly expressed across many different mesoderm subtypes76, while 
Tbx6 is more selectively expressed in early forming paraxial mesoderm cells77. To verify 
reporter line functionality, mesoderm formation was induced by activating Wnt signaling as 
previously reported38–42. For differentiation, mouse ESCs were seeded at low density and 
allowed to attach and grow for two days. After two days, canonical Wnt signaling was 
activated via the addition of Wnt3a (50ng/ml) and/or CHIR99021 (3uM) over the next four 
days (days 2-6, Fig.3.1). As anticipated, Wnt pathway activation increased the expression 
of both reporters over the four-day treatment period. Interestingly, the location and 
organization of cells expressing T and Tbx6 reporters were noticeably different (Fig.3.1, 
C-E). Strong T-Cherry reporter expression appeared at the center of the colony and this 
group of cells over time increased three dimensionally in size as a spherical mass. In 
contrast, the majority of Tbx6+ cells were present around the periphery as a flatter cellular 
monolayer. At earlier stages of differentiation, weak T-Cherry reporter expression could 
also be detected in the Tbx6+ cell population (Fig.3.1, C1-C3).  
 
To confirm the fidelity of reporter expression, cultures were FACS sorted for Tbx6+ 
and T+ cells and endogenous gene expression for these respective reporters were  
  
28 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 
29 
 
Figure 3.1. Paraxial mesoderm induction in a Tbx6 and Brachyury dual reporter 
mouse ESC model. (A) DNA maps of reporter genes and mesoderm differentiation 
strategy. Tbx6-H2B-EYFP was targeted into the endogenous gene locus as previously 
described [1]. The Brachyury-Cherry reporter was introduced into ESCs as a BAC 
transgene. Established stem cells were plated for differentiation and allowed to adjust to 
the base differentiation media for two days, followed by four days of differentiation with 
mesoderm inducing factors. (B-E) Imaging of Tbx6 (green) and Brachyury (red) reporter 
expression during ESC differentiation in response to Wnt3a and CHIR99021 from days 2 
to 6. (C1-C3) Imaging of reporter expression at higher magnification on day 4 suggests 
that Tbx6+ and Brachyury+ cells are largely distinct populations. (F) Gene expression 
analyses on sorted cell populations confirms the fidelity of reporter expression with 
endogenous gene expression and enrichment of paraxial mesoderm genes in the Tbx6+ 
population. Data shown as mean ± SEM (n = 3, *p < .05, where * denotes the comparison 
of T+ to Tbx6+). 
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examined (Fig.3.1, D and E). T was ~33 fold higher in the T-Cherry population compared 
to Tbx6-EYFP cells. In contrast, Tbx6 was nearly ~30 fold higher in the Tbx6-EYFP 
population compared to T-Cherry cells. Given our interest in paraxial mesoderm, we also 
examined the expression of Mesenchyme Homeobox 1 (Meox1), Hoxb1, and Mesogenin 
(Msgn1) and found that all three gene markers were highly enriched in the Tbx6+ cell 
population (Fig.3.1F). Thus, the gene expression analyses on sorted T and Tbx6 cell 
populations supported the fidelity of these reporter genes. 
 
3.3.2. Inverse Agonism of Retinoic Acid Receptors Augments Mesoderm Induction 
A large body of work has demonstrated the importance of repressing retinoic acid 
signaling for proper tail bud elongation60,67,68,78,79. Additionally, repression of BMP signaling 
has also been shown to promote the formation of paraxial mesoderm over lateral plate 
mesoderm41,80. Therefore, we decided to test AGN193109, a pan-RAR inverse agonist 
and Noggin, a BMP inhibitor, for their ability to promote paraxial mesoderm formation in 
the presence and absence of Wnt3a/CHIR99021 treatment. Gross evaluation of Tbx6 
reporter expression (Fig.3.2 A-H, green) in living cultures only 2 days after treatment 
revealed a noticeable benefit when AGN193109 (1uM) was combined with 
Wnt3a/CHIR99021 (Fig.3.2, compare G and H to A-F). In contrast, there was no apparent 
benefit to Noggin (100ng/ml) treatment. To more quantitatively assess Tbx6 and T 
reporter expression, cultures were harvested and analyzed by FACS analyses three days 
after treatment. Consistent with our observations, FACS analyses showed that 
AGN193109 significantly augmented the ability of Wnt3a/CHIR99021 to stimulate 
mesoderm formation (Fig.3.2. compare G’ and H’ to A’-F’). Relative to Wnt3a/CHIR99021 
alone, the addition of AGN193109 not only increased the T+ (12.2% to 18.8%) and Tbx6+ 
(5.8% to 12.7%) cell populations, but also increased the T+/Tbx6+ (2.4% to 13.1%) cell  
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Figure 3.2. Inverse agonism of RARs augments mesoderm induction.   
(A-H) Representative images of reporter expression under separate and combined 
treatment conditions for Wnt3a/CHIR99021, AGN193109, and Noggin after 2 days of 
treatment (day 4 of differentiation). (A’-H’) FACS analyses of Tbx6 and Brachyury reporter 
expressing cells after 3 days of treatment (day 5 of differentiation) under the same 
treatment combinations as shown in (A). RAR inhibition resulted in substantial increases 
in the percentage of Tbx6+, T+, and Tbx6+/T+ cells. Gates were set based on 
undifferentiated control stem cells. (I) Gene expression analyses on day 5 for paraxial 
mesoderm gene markers Tbx6, Msgn1, Meox1, and Hoxb1 using indicated combinations 
of Wnt3a/CHIR99021, AGN193109, and Noggin. Dramatic up-regulation of all paraxial 
gene markers was observed when AGN193109 was added with Wnt3a/CHIR99021with or 
without Noggin relative to their respective individual treatments. Data shown as mean ± 
SEM (n = 3, *p < .05, **p < .05, where * and ** denotes the comparison of treatments 
between Wnt3a, CHIR99021 to Wnt3a, CHIR99021 with AGN193109). 
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population. However, inverse agonism of RARs alone only had a marginal impact on 
mesoderm induction (Fig.3.2C’). FACS analyses also showed that Noggin treated cultures  
had no benefit with regard to promoting the early formation of paraxial mesoderm (Fig.3.2, 
compare B’ to F’).  
 
The synergism of AGN193109 with Wnt3a/CHIR99021 treatment was also 
evaluated by gene expression analyses (Fig.3.2I). For these studies, we examined the 
expression of paraxial mesoderm gene markers Tbx6, Msgn1, Meox1, and Hoxb1. 
Consistent with the assessment of Tbx6 reporter expression in culture and by FACS 
analyses, the combined treatment of AGN193109 with Wnt3a/CHIR99021 substantially 
augmented the expression of all four paraxial mesoderm gene markers relative to control 
and individual treatments. However, the combined versus individual treatment of 
AGN193109 with Wnt3a/CHIR99021 did not increase T expression, which is not restricted 
to paraxial mesoderm (data not shown). 
 
3.3.3. Epiblast State Enables More Efficient Differentiation into Paraxial Mesoderm 
While Wnt activation in conjunction with RAR inverse agonism did have a 
combinatorial benefit to promoting the formation of paraxial mesoderm, the overall 
efficiency of differentiating mouse ESCs directly into mesoderm cells was rather modest. 
Further, visual aspects of the differentiation process suggested to us that perhaps the 
mouse stem cell state was not the ideal “cell state” from which to derive mesoderm. First, 
adding Wnt3a and CHIR99021 earlier than day 2 did not result in faster differentiation 
(data not shown and Fig.3.3), suggesting drifting away from the stem cell state may be 
required for mesoderm formation. Second, even with the delayed addition of Wnt agonists 
at Day 2 of culture, the response of mouse ESCs colonies was still quite variable. Some 
attached colonies formed spherical mounds with no reporter expression, while other  
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Figure 3.3. Conversion of mouse ESCs to epiblast state enhances paraxial 
mesoderm differentiation. (A) Schematic depiction of differentiation conditons. Note day 
1 conditions for comparing delayed (2i), direct (FC), and epiblast (FA) transitions into 
mesoderm. (B) Representative images of reporter expression on day 3 of differentiation 
showing robust Tbx6 reporter expression and spreading of T+ cells following epiblast (FA) 
transition. T+ cells remained clustered following direct mesoderm induction (FC), with 
limited Tbx6 reporter expression. The persistence of numerous mounded, reporter-
negative colonies occurred with the 2i and FC transitions (white arrows), which were 
absent from epiblast-transitioned cultures. (C) Day 3 FACS analysis shows epiblast 
transition (FA) followed by two days of mesoderm differentiation generated considerably 
more Tbx6+ cells compared to just two (2i) or three (FC) days of mesoderm differentiation, 
with control stem cells shown for comparison. (D) Day 3 gene expression indicated 
elevated levels of early mesoderm genes T, Wnt3a, and Fgf8 and substantial increases in 
the paraxial markers Tbx6 and Msgn with FA transition compared to 2i or FC, which also 
retained expression Sox2. Data shown as mean ± SEM (n = 3, *p < .05, where * denotes 
the comparison of FA treatment to both 2i and FC). 
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colonies formed T+ spherical mounds (Figs.3.1,3.2). We also noted that mouse ESC 
colonies that stayed flatter favored the formation of cells expressing the Tbx6 reporter. 
This latter detail suggested that first converting mouse ESCs into epiblast-like cells, which 
unlike mouse ESCs grow in monolayer, could be more conducive to forming paraxial 
mesoderm. 
 
To test this idea, we compared mouse ESCs directly differentiated into mesoderm 
to mouse ESCs first differentiated into epiblast-like cells by treating with FGF2 and Activin 
A prior to switching to mesoderm conditions (Fig.3.3A). Surprisingly, these studies 
revealed that just a single day of differentiation towards the epiblast state followed by 
mesoderm induction resulted in a dramatic enhancement in the formation of Tbx6+ cells 
(Fig.3.3). Imaging of Tbx6 reporter gene expression two days after mesoderm induction 
revealed how transitioning into the epiblast state noticeably increased the abundance of 
Tbx6+ cells (Fig.3.3B, compare 2i or FC to FA). More quantitative metrics by FACS 
revealed that with one day of epiblast treatment, the percentage of Tbx6+ cells increased 
to 65-75% (Fig.3.3C). Gene expression analyses showed paraxial mesoderm marker 
genes Tbx6 and Msgn were highly expressed in mesoderm following epiblast 
differentiation. In contrast, mouse embryonic stem cells that were transitioned into 
mesoderm for two or three days had much lower levels of Tbx6 and Msgn, and retained 
expression of Sox2, suggesting many cells in the culture did not undergo mesoderm 
differentiation. Consistent with this thinking, FACS analyses and imaging showed a 
prevalence of cells expressing neither the T nor Tbx6 reporters following direct 
differentiation from mESCs into mesoderm. 
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3.3.4. RAR Inverse Agonist Treatment Suggests Two Distinct Roles Exist in 
Regulating Early Paraxial Mesoderm Formation 
 With the inclusion of an epiblast differentiation step, we decided to revisit the 
benefit of treating cells with the RAR inverse agonist AGN193109, which promoted 
mesoderm differentiation (Fig.3.2). However, with the addition of an epiblast differentiation 
step, we also wanted to determine which stage of differentiation; epiblast, mesoderm, or 
both, would inverse agonist treatment be more beneficial. Therefore, we compared the 
differentiation of mouse ESCs treated with AGN193109 at the epiblast step (E*), 
mesoderm step (M*), or both (E*M*) to ESCs differentiated in the absence of the inverse 
agonist (EM) (Fig.3.4A, diagram). Visual examination of cultures showed modest 
increases in the level of Tbx6 reporter expression with RAR inverse agonist treatment with 
continuous treatment (E*M*) having the brightest level of reporter expression (Fig.3.4B). 
FACS analyses substantiated these observations showing the intensity of Tbx6 reporter 
expression was considerably higher in E*M* treated cultures compared to EM cultures. 
Further, FACS analyses also showed that the continuous RAR inverse agonist treatment 
increased the yield of Tbx6+ cells to 90%, compared to 65-75% without treatment.  
 
 Gene expression analyses of paraxial gene markers also suggested that RAR 
inverse agonist treatment had distinct stage-dependent effects on paraxial mesoderm 
formation. While the examination of early gene markers such as Tbx6, Msgn, and Fgf8 
showed minimal changes in gene expression, gene markers associated with the transition 
of presomitic to somitic mesoderm Mesp2, Ripply2, and Meox1 showed remarkable 
changes with inverse agonist treatment. Treatment at the epiblast stage (E*) resulted in 
the highest increase in Meox1 expression at the mesoderm stage. However, continuous 
RAR inverse agonist treatment (E*M*) had lower levels of Meox1 expression compared to 
E*, with Mesp2 and Ripply2 being highly expressed.  
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Figure 3.4. Distinct roles of RAR inverse agonist treatment in regulating 
paraxial mesoderm formation and maturation. (A) Schematic of differentiation 
conditions modifying the strategy of epiblast transition into mesoderm from Fig. 3.3 
to assess the stage-dependent effects of AGN193109 treatment as indicated with 
asterisks (*). (B) Representative images of reporter expression on day 3 of 
differentiation showing continuous RAR inverse agonist treatment (E*M*) having 
the brightest level of reporter expression, confirmed by FACS analysis in (C) 
comparing E*M* cultures to EM and stem cell control cultures. (D) Gene 
expression comparing levels of early gene markers Tbx6, Msgn, and FGF8 
showed minimal changes between treatments. However, markers indicating a 
transition to somitic mesoderm, Meox1, Mesp2, and Ripply2, were remarkably 
higher with inverse agonist treatment, especially with treatment during epiblast 
stage. This benefit was also evidenced by the down-regulation of non-paraxial 
markers Eomes, Mixl1, and Lhx1 in (E). (F) Model of paraxial mesoderm lineage 
differentiation following epiblast transition and the stage-dependent effects of 
AGN193109 treatment. Data shown as mean ± SEM (n = 3, *p < .05, **p<0.05, 
***p<0.05 where * denotes the comparison of E* to EM, ** denotes the comparison 
between M* to EM, and *** denotes the comparison of E*M* to EM). 
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In contrast to detecting stable or increasing expression of paraxial mesoderm 
marker genes, the expression of lateral plate mesoderm, intermediate mesoderm, and 
endoderm marker genes were either not detected or down-regulated (Fig.3.4E). Lateral 
plate mesoderm marker genes Tal1 and Kdr were undetectable. Intermediate mesoderm 
marker gene Osr1 was undetectable, while Lhx1 (Fig.4E) was down-regulated almost 3-
fold by inverse agonist treatment just at the epiblast step (E*) and 4-fold with continuous 
inverse agonist treatment (E*M*). Genes also important for endoderm specification Eomes 
and Mixl1 were down-regulated 4- and 5-fold, respectively by treatment with the inverse 
agonist at just the epiblast step (E*). 
 
 Taken together, this data suggests that inverse agonism of RARs at the epiblast 
stage promotes the future transition of epiblast cells towards the presomitic mesoderm 
lineage over other embryonic lineages, but continued treatment at the mesoderm step 
represses further maturation into somitic mesoderm (Fig.3.4F). It is well established that 
retinoic acid signaling is involved in the maturation of presomitic unsegmented mesoderm 
into somitic segmented mesoderm, consistent with the lack of robust Meox1 expression 
with continued treatment (Fig.3.4D). Further, this likely explains why the highest 
expression levels and percentage of cells with Tbx6 reporter activity were present in the 
E*M* treated cultures as it is known that Tbx6 expression decreases during paraxial 
mesoderm maturation81. 
 
3.3.5. Inverse Agonism of RARs Directs Epiblast Cells Towards the Paraxial 
Mesoderm Fate  
With evidence that treatment with AGN193109 at the epiblast step of differentiation 
can influence the future differentiation of epiblast cells into paraxial mesoderm, we 
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decided to examine the effect of RAR inverse agonist treatment on gene expression 
during epiblast differentiation. However, in contrast to the prior experiment where epiblast 
differentiation lasted just a single day, we decided to carry out epiblast differentiation for 
three days in the presence and absence of inverse agonist treatment (Fig.3.5). The 
conversion from the stem cell state to the epiblast state was detected by the rapid down 
regulation of the inner cell mass marker gene Rex1 (Fig.3.5A) and the dramatic increase 
in the epiblast marker gene Fgf5 (Fig.3.5B). The expression of pluripotency marker gene 
Oct4 remained unchanged throughout the three-day period, while Nanog expression 
abruptly dropped, but then gradually increased (Fig.3.5C,D). The pluripotency marker 
gene Sox2 gradually decreased over the three-day differentiation period with slightly lower 
expression levels with inverse agonist treatment. Collectively, the examination of these 
gene markers did not reveal any dramatic changes in gene expression in the addition of 
AGN193109 treatment. 
 
However, examination of caudal epiblast genes Cyp26a1, T, and Fgf8 and early 
markers of paraxial mesoderm Msgn and Tbx6 did reveal that inverse agonist treatment 
was somehow promoting meaningful changes in epiblast gene expression (Fig.3.5F-J). By 
day three of epiblast differentiation in the presence of inverse agonist treatment, Cyp26a1 
and T were 6-fold higher (Fig. 3.5F, G), Fgf8 was 3-fold higher (Fig.3.5H), and Msgn and 
Tbx6 were 45- and 9-fold higher, respectively, compared to epiblast conditions alone (Fig. 
3.5I, J). This delayed yet pronounced increase in a subset of caudal epiblast marker 
genes that are largely responsible for driving axial growth suggests that inverse agonism 
of RARs in epiblast cells can promote their direction of differentiation towards the paraxial 
mesoderm cell lineage. 
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Figure 3.5 
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Figure 3.5. Treatment of epiblast cells with RAR inverse agonist favors a paraxial 
mesoderm fate. Gene expression analyses over three days of epiblast differentiation with 
(FA+AGN) or without (FA) inverse agonist treatment compared to stem cell (2i) control. 
(A,B) Rapid loss of Rex1 expression and dramatic increase of Fgf5 expression confirms 
transition from stem cell to epiblast. (C-E) Oct4 expression remained unchanged, while a 
sharp drop and then gradual increase in Nanog expression, and a steady decrease in 
Sox2 expression occurred in FA and FA+AGN conditions alike. (F-H) Caudal epiblast 
genes Cyp26a1, T, and Fgf8 were strongly increased over three days of epiblast 
differentiation, while including AGN193109 treatment showed even greater enhancement 
of expression levels. (I,J) Inverse agonist treatment also led to substantial increases in 
paraxial mesoderm markers Msgn and Tbx6 by day 3 of epiblast differentiation not seen in 
the FA treatment, suggesting AGN193109 promotes epiblast differentiation into the 
paraxial mesoderm lineage. Data shown as mean ± SEM (n = 3, *p < .05, where * denotes 
the day 3 comparison between FA to FA with AGN193109). 
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3.4. Discussion 
In this study, we showed that the differentiation of paraxial mesoderm directly from the 
mouse ESC “naïve” state is considerably less efficient than differentiation from the 
epiblast state. This work also showed how the use of AGN193109, a pan-RAR inverse 
agonist, when added at the epiblast and mesoderm steps of differentiation promoted the 
formation of paraxial mesoderm over other mesoderm and endoderm cell lineages. 
Further, continued treatment of AGN193109 during mesoderm differentiation repressed 
the maturation of presomitic mesoderm into somitic mesoderm. This two-step, three-day 
differentiation protocol resulted in an extremely high yield of Tbx6+ paraxial mesoderm 
cells (90%) from mouse ESCs. Taken together, this work introduces a novel and efficient 
approach to generate paraxial mesoderm from mouse ESCs and suggests a very early 
retinoic acid independent role exists for RARs in epiblast cells and early mesoderm 
progenitor cells that promotes their differentiation into the paraxial mesoderm lineage.  
 
3.4.1. Epiblast State is a Better Staging Ground for Generating Paraxial Mesoderm 
While our studies and work by others 41,42,82,83 have shown that mesoderm 
differentiation directly from the mouse ESC naive state is possible, we also demonstrate 
how paraxial mesoderm formation initiated after an epiblast transition works with greater 
efficiency. We speculate that the likely reason for this relates to the conflicting roles of β-
Catenin as a factor that promotes both stem cell pluripotency and mesoderm 
differentiation 42,84–88. CHIR99021, the GSK3 inhibitor that results in β-Catenin stabilization 
is one of two stemness molecules in 2i stem cell maintenance media, but also is a widely 
used molecule for mesoderm differentiation 82,89–91. Indeed, at the DNA level, β-Catenin 
has been shown to occupy regulatory regions on both stemness and mesoderm inducing 
genes in mouse ESCs 86. Further, in naïve cells β-Catenin represses TCF3 function to 
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maintain the naïve state, while TCF3 is important for the transition from naïve to the 
primed epiblast state 84,88.  
 
With this in mind, we and others 82,83 have noted that mouse ESCs do not 
immediately respond to mesoderm inducing factors, as the removal of pluripotency 
conditions for up to 48 hours is often necessary to ensure a higher percentage of cells exit 
the stem cell state and effectively respond to mesoderm inducing factors. In contrast, we 
show that naïve mouse ESCs can rapidly and uniformly respond to epiblast differentiation 
conditions, indicating that FGF and Activin signaling pathways do not provide conflicting 
cues that would promote the naïve state, but in fact counter naïve stemness regulators to 
allow uniform differentiation into the epiblast state. While pluripotency genes are still 
expressed at the epiblast state, how they are regulated has markedly changed and is 
independent of β-catenin regulation 14,88,92,93. Thus, the stabilization of β-catenin via 
treatment of CHIR99021 at the epiblast stage no longer provides conflicting signals to 
promote stemness and mesoderm, thereby allowing efficient mesoderm differentiation to 
be initiated. 
 
3.4.2. Inverse Agonism of RARs Steers Epiblast Cells toward a Caudal Fate 
 In this study we show how the addition of an RAR inverse agonist, AGN193109, 
promoted the expression of caudal epiblast marker genes as well as early paraxial 
mesoderm marker genes (Fig.3.4). However, the mechanism(s) behind this effect remain 
unclear. Work by others has shown that when inverse agonists bind to RARs, a change in 
protein structure occurs that stabilizes the association of RARs with transcriptional co-
repressors NCoR and SMRT 94–98. In contrast, when RA binds to RARs they generally 
associate with transcriptional co-activators NCoA. With that in mind, in vivo studies have 
shown that RARs are expressed in the epiblast, which is devoid of RA signaling based on 
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RARE-LacZ reporter characterization 99. Thus, it is likely that RARs function in the epiblast 
in a RA independent manner, but their exact role in the epiblast remains unclear. The 
work presented here suggests that RARs may function in the absence of RA to promote 
caudal epiblast formation and paraxial mesoderm formation. 
  
It is generally accepted that treatment with RAR inverse agonists is thought to 
mimic the unliganded conformation and function of RARs; as in the absence of RA, RARs 
have been shown to associate with co-repressors NcoA and SMRT 96–98,100. Therefore, it is 
conceivable that differentiation performed in the absence of vitamin A, the precursor to 
RA, should mimic the effects of inverse agonist treatment. In support of this thinking, 
mouse ESCs deficient of Aldha1, which encodes for an enzyme necessary for the 
synthesis of RA, showed substantial up-regulation of early paraxial mesoderm gene 
markers Tbx6 and Msgn 101. However, we performed our differentiation studies in vitamin 
A deficient media and the addition of inverse agonist still had noticeable benefits to 
paraxial mesoderm formation. In fact, the up-regulation of Tbx6 and Msgn during 
prolonged epiblast differentiation appeared to be highly dependent on the addition of 
AGN193109 (Fig.3.5). With that said, mouse ESCs are commonly maintained in serum 
free media containing vitamin A, and retinol derivatives stored inside cells102may persist 
over the initial days of differentiation, which may impact early cell fate decisions. Also, 
work by others suggests vitamin A is a valuable component to the stemness and growth of 
mouse ESCs. RA-independent and possibly RA-dependent roles for vitamin A are 
important for maintaining rates of mouse ESC proliferation and pluripotency 103–108. 
Therefore, maintaining mouse ESCs in the absence of vitamin A is not likely a viable 
option, but could interfere with efficiency of subsequent differentiation steps as our studies 
possibly suggest. Thus, the application of RAR inverse agonists to rapidly outcompete any 
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effects from low levels of RA to promote paraxial mesoderm differentiation is a simple 
solution. 
3.4.3. RAR Inverse Agonism Represses Paraxial Mesoderm Maturation 
While RAR inverse agonist at the epiblast step of differentiation promoted paraxial 
mesoderm induction, our studies also indicated that continuous treatment during the 
mesoderm differentiation step delayed further maturation. Continuous inverse agonist 
treatment resulted in reduced Meox1 expression, while at the same time generated the 
highest percentage of Tbx6+ cells (90%). Consistent with our outcomes, past embryonic 
studies have shown that severe axial truncation occurs when excessive levels of retinoic 
acid signaling occurs 79. Excessive levels of RA overcome the threshold of Cyp26a1 
degradation and bind RARγ resulting in truncation 109. In contrast to RA treatment and 
similar to our outcomes, in vivo studies in Xenopus have shown that the addition of pan-
RAR and RARγ specific inverse agonists delayed the maturation of unsegmented paraxial 
mesoderm to maintain a caudal progenitor pool 110. While the benefit of continuous 
inverse agonist treatment at the mesoderm step could be argued, we believe it is likely 
that delaying paraxial mesoderm maturation during embryonic stem cell differentiation will 
maintain better synchrony among cells in culture, which will provide a more uniform 
cellular response for subsequent differentiation steps.  
  
In these studies, we highlight the benefit of epiblast differentiation and RAR 
inverse agonism as an approach to increase paraxial mesoderm formation from mouse 
ESCs. By enhancing the guidance of ESCs into paraxial mesoderm, downstream efforts 
to generate different skeletal cell types will be improved. 
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Figure 3.6. Individual channel images for paraxial mesoderm induction in a Tbx6 
and Brachyury dual reporter mouse ESC model.  Imaging of DIC, Brachyury (red) and 
Tbx6 (green) and reporter expression during mESC differentiation in reponse to Wnt3a 
and CHIR99021 from days 2 to 6. Supplemental figure shows single channel images that 
correspond to the merged fluorescent images shown in Fig.3.1B-E.  
 
 
Figure 3.7. Individual channel images for inverse agonism of RARs augments 
mesoderm induction.  Imaging of DIC, Brachyury (red) and Tbx6 (green) and reporter 
expression during mESC differentiation in reponse to separate and combined treatment 
conditions for Wnt3a/CHIR99021, AGN193109, and Noggin after 2 days of treatment (day 
4 of differentiation). Supplemental figure shows single channel images that correspond to 
the merged fluorescent images shown in Fig.3.2 A-H. 
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DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS 
INTO THE PARAXIAL MESODERM LINEAGE 
 
4.1. Introduction 
 
Embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) technologies 
have revolutionized research and development of treatments for many different types of 
diseases, including those that impact the human skeleton. However, an essential 
prerequisite for using ESCs/iPSCs for these purposes requires an in depth understanding 
of how to reliably direct pluripotent stem cells into different skeletal cell types.  Many 
published methodologies have placed great emphasis on the pluripotency state of 
ESCs/iPSCs by either (1) directly differentiating ESCs into mature skeletal cell types2,111 
or (2) first differentiating ESCs into mesenchymal stem cells prior to differentiating them 
into mature skeletal cell types112,113.  Comparatively, fewer studies have acknowledged the 
embryonic state of pluripotent cells and made efforts to differentiate ESCs/iPSCs along a 
multi-stepped embryonic program. At the same time, most investigators would agree that, 
if possible, following an embryonic program would likely yield much greater information 
about human skeletal development and likely produce higher quality skeletal progenitors 
for therapy. 
 
The skeleton is derived from three distinct embryonic lineages. Craniofacial 
structures are mostly derived from the cranial neural crest and with some contribution 
from the anterior paraxial mesoderm. The appendicular skeleton is derived from lateral 
plate mesoderm. The axial skeleton is largely derived from paraxial mesoderm with the 
exception of the intervertebral disc, which is derived from notochordal cells6,7.  Out of 
these three lineages, we were compelled to investigate paraxial mesoderm formation 
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because paraxial mesoderm entirely contributes to formation of the somites, which retain 
the precursors to a variety of skeletal lineages including chondrocyte, osteoblast, 
tenocyte, myoblast, and dermal fibroblast.  Thus, the benefit of investigating paraxial 
mesoderm formation is that it may lead to discovering how to generate a variety of 
skeletal cell types, not just one.   
 
A large body of knowledge exists regarding how paraxial mesoderm formation 
occurs during embryogenesis.  A key regulator of paraxial mesoderm specification is the 
transcription factor T-box 6 (Tbx6).  Quite strikingly, targeted loss of Tbx6 in mice resulted 
in the formation of ectopic neural tubes at the expense of paraxial mesoderm formation30.  
Recently, the mechanism behind this phenotype was reported where Tbx6 represses 
Sox2 to direct caudal epiblast cells into the paraxial mesoderm lineage28.  In a similar 
fashion, targeted loss of Wnt3a also resulted in broader contribution of epiblast cells into 
the neural ectoderm fate at the cost of forming paraxial mesoderm29.  In general, 
canonical Wnt signaling is essential for mesoderm formation.  Gene targeting studies in 
mice have shown how several members of the Wnt pathway are required for mesoderm 
formation including Wnt3, β-Catenin, Lef1/Tcf1 double mutants, and LRP5/LRP6 double 
mutants37,86.  Interesting, ESC differentiation work by others has also indicated that the 
level of Wnt signaling may be important for the type of mesoderm specified with higher 
levels being important for paraxial mesoderm formation. 
 
In contrast to Tbx6 and the Wnt pathway, which promote paraxial mesoderm 
formation, retinoic acid, a derivative of vitamin A, at teratogenic levels can cause a variety 
of embryonic defects including severe caudal truncation68.  During early embryonic 
development Cyp26a1, which encodes for an enzyme that breaks-down retinoic acid is 
expressed throughout the epiblast and becomes progressively restricted to the anterior 
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and caudal ends of the developing embryo. Targeted loss of Cyp26a1, mimics teratogenic 
levels of retinoic acid, resulting in severe caudal truncation60.  Examination of Wnt3a and 
FGF8, genes expressed in the tailbud and essential for paraxial mesoderm formation 
revealed their down regulation in Cyp26a1 mutants58,114. 
 
In this study, we have undertaken efforts to direct human ESCs into paraxial 
mesoderm.  To have a readout for mesoderm and paraxial mesoderm formation, we have 
created and utilized a human ESC Tbx6-Cherry/Ubiquitin-C-Citrine transgenic reporter 
line. H9 human ESCs.  Consistent with work by others, higher levels of Wnt signaling 
overall lead to greater mesoderm formation including increased Tbx6 expression.  
Additionally, we provide evidence that inhibition of retinoic acid signaling in the presence 
of Wnt activation using the small molecule AGN193109 dramatically increases paraxial 
mesoderm formation.  
 
4.2. Materials and Methods 
 
4.2.1 Cell Culture 
H9 ESCs and Tbx6-Cherry/UbiquitinC-Citrine H9 human ESCs were maintained in 
hESC media (mTeSR, Stemcell Technologies) on a feeder layer of irradiated mouse 
embryonic fibroblasts or Matrigel.  Prior to differentiation of human ESCs, cells were 
transitioned to tissue culture dishes (Thermo Scientific) coated with Matrigel (Corning) and 
grown for a minimum of 24 hours.  For differentiation, cells were grown in a 3:1 mixture of 
IMDM and Ham’s F12 (Life Technologies) N2, B27 without vitamin A, 0.05% BSA, 
100U/ml penicillin, 100ug/ml streptomycin, 1.5x10-4 M monothioglycerol, and 0.5mM 
ascorbic acid.  50ng/ml Wnt3a, 3uM CHIR99021 (Stemgent), 1uM AGN193109 (Santa 
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Cruz Biotechnology), and 100ng/ml Noggin (PeproTech) were added in different 
combinations. 
 
4.2.2. Generation of Fluorescent Reporter H9 ESC Line 
For the creation of Tbx6-Cherry/UbiquitinC-Citrine dual reporter H9 human ESCs, 
BAC clone RP11-114A14 (Children’s Hospital Oakland Research Institute) containing the 
TBX6 gene was engineered with a Cherry fluorescent reporter gene using bacterial 
recombination strategies.  In brief, a homology arm was PCR amplified from the BAC 
clone using Pfx DNA polymerase (Life Technologies) 5’-
CTCTGCGGCCGCCCTGCACTTTCCCTCTGTTCACGCTGCT-3’ (sense) and 5’-
CTCTGGATCCGTTGTAGTTCCGTCTGGCCTCAGGTCT-3’ (antisense). The DNA 
fragment was cloned into the Not1-BamH1 site of pLD53.SC2-Cherry and Rec A was 
used to integrate the reporter into the BAC clone.  The BAC clone was then retrofitted with 
puromycin resistance through Cre/LoxP recombination by co-electroporating pCTP, which 
expresses Cre recombinase and pUni, which contains an EF1α-puromycin resistance 
gene and a LoxP site into RP11-114A14 competent bacteria.  A Citrine fluorescent 
reporter gene was inserted into a PiggyBac plasmid vector containing the human Ubiquitin 
C promoter and a neomycin resistance cassette to create pPB.UbiquitinC-Citrine 
(generously provided by Allan Bradley and the Wellcome Trust Sanger Institute).  For 
lipofection, H9 ESCs were passaged to Matrigel-coated plates grown to 50-70% 
confluence.  5 ug purified BAC, 2 ug purified UbiquitinC-Citrine plasmid, and 1 ug 
hyperactive piggyBac transposase (generously provided by Nancy L. Craig) expression 
vector were co-transfected using Lipofectamine 3000 (Life Technologies) according to 
manufacturer protocol.  Selection with puromycin (0.25ug/ml) was initiated 3 days after 
transfection.  Resistant clones were picked and expanded after two weeks (Fig. 4.1).   
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4.2.3. FACS Analysis and Sorting 
 ESCs were washed twice with cold PBS then digested using Accutase (StemCell 
Technologies) and centrifuged at 300g for 5 minutes.  In brief, cells were resuspended in 
100 ul FACS staining buffer (PBS, 0.5% BSA, 2 mM EDTA, pH 7.2) and 2 ul of SSEA4 
eFluor 660 (eBioscience) antibody was added to the cell suspension. The cell-antibody 
suspension was mixed well and incubated for 10 minutes in the dark at 4°C.  Cells were 
then washed by the addition of 1-2 ml of buffer and subsequently centrifuged at 300g for 
10 minutes. Supernatant was aspirated and the cells were resuspended in 500 ul of 
staining buffer for FACS analysis. FACS analyses were carried out on a Becton-Dickinson 
LSRII and FACS sorting was carried out using a FacsAria II (UCHC Flow Cytometry 
Core). 
 
4.2.4. RNA Purification and Quantitative RT-PCR   
RNA purification was carried out using Nucleospin RNA II kit (Macherey-Nagel) according 
to manufacturer’s recommendations. cDNA was prepared from 1ug of RNA/sample using 
the SuperScript II Reverse Transcriptase (Life Technologies). QPCR was carried out 
using SybrGreen PCR Master Mix (Qiagen) in an ABI 7900HT (Applied 
Biosystems).  PCR primer sequences (Table 4.1) for gene expression analyses were 
designed using qPrimer Depot75 (http://primerdepot.nci.nih.gov) a database of optimized 
primers for RefSeq genes.   
 
4.2.5. Microscopy and Imaging 
Cells in culture were imaged using a Zeiss Observer Z.1 inverted microscope.  
Fluorescence was detected using the following filter sets (Chroma Technology): HQ 
500/20, HQ535/30, Q515lp, for EYFP, and HQ577/20x, HQ640/40m, Q595lp for Cherry 
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fluorescent protein.  Images were captured using an Axiocam MRc digital camera and Zen 
software (Zeiss). 
 
 
 
Figure 4.1. Generation of dual reporter H9 ESC line. Retrofitting of the mCherry 
fluorescent reporter into the TBX6-containing bacterial artificial chromosome via 
homologous recombination. Co-transfection of H9 ESCs with the TBX6-mCherry vector, 
Ubiquitin Citrine vector and PiggyBac Transposase vector via the Lipofectamine
 
3000 
system created dual reporter clones. Puromycin selection and PCR screening confirmed 
genomic integration of reporter constructs115. 
 
 
 
Table 4.1. Human QPCR Primers 
Gene Sense (Forward) Antisense (Reverse) Species 
GAPDH 5’-AAGGTGAAGGTCGGAGTCAA-3’ 5’-TTAAAAGCAGCCCTGGTGAC-3’ Human 
TBX6 5’-CAACTGAAGATTGCAGCCAA-3’ 5’-CCGCAGTTTCCTCTTCACAC-3’ Human 
MSGN1 5’-GGAATTACCTGCCACCTGTC-3’ 5’-GTCTGTGAGTTCCCCGATGT-3’ Human 
HOXB1 5’-GGTTAAGAGAAACCCACCCA-3’ 5’-CAGTTCTGTCAGCTGCCTTG-3’ Human 
MEOX1 5’-GAGAAGAAATCATCCAGGCG-3’ 5’-AAGGCCGTCCTCTCCTTG-3’ Human 
SOX2 5’-GCGAACCATCTCTGTGGTCT-3’ 5’-GGAAAGTTGGGATCGAACAA-3’ Human 
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4.3 Results 
 
4.3.1 AGN193109 and Wnt Synergize to Promote Paraxial Mesoderm Differentiation 
of H9 ESCs 
We engineered H9 human ESCs with a TBX6-Cherry (red) BAC transgene and 
UbiquitinC-Citrine (green) defined promoter reporter to investigate the generation of 
paraxial mesoderm (Fig. 4.1). For differentiation, H9 cells were passed in small patches 
on Matrigel, allowed to recover for one day in stem cell media, then transitioned to a 
similar defined media used to differentiate mouse ESCs.  Similar to our previous studies 
using mouse ESCs, we compared the ability of Wnt3a/CHIR99021 treatment separate 
and combined with AGN193109 and Noggin to stimulate paraxial mesoderm formation 
based on TBX6 reporter expression (Fig.4.2).  After three days of treatment, TBX6 
reporter expression was absent in controls (Fig.4.2A) and only weakly detected in the 
presence of Wnt3a/CHIR99021 (Fig.4.2B).  However, the combined treatment of 
Wnt3a/CHIR99021 and AGN193109 resulted in a robust increase in TBX6 reporter 
expression (Fig.4.2C). The organization of the differentiating colony shown is 
representative of what we have observed in other colonies under these conditions. 
Interestingly, Noggin treatment at this stage was largely inhibitory to the formation of 
Tbx6+ cells mediated by Wnt activation and RAR inhibition (Fig.4.2D).  To more 
quantitatively assess the generation of Tbx6+ cells, we carried out FACS analyses of 
these different treatments (Fig.4.2). Consistent with our visual observations, roughly 27% 
of the total cell population was Tbx6+ when treated with Wnt3a/CHIR99021 and 
AGN193109. The addition of Noggin reduced the percentage of Tbx6+ cells to 10%.  Less 
than 0.1% Tbx6+ cells were detected in control and Wnt3a/CHIR99021 cultures at these 
early stages of differentiation. 
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Figure 4.2. Retinoic Acid Inverse Agonism Increases TBX6 Reporter Expression. 
Fluorescent reporter expression in cultures treated for four days with the indicated 
combinations of Wnt3a, CHIR99021, AGN193109, and Noggin. TBX6-mCherry (red) and 
UbiquitinC-Citrine (green) reporter expression with corresponding FACS analyses 
showing percentages of TBX6+ populations indicated stimulation with Wnt3a and 
CHIR99021 coupled with retinoic acid receptor pathway inhibition via AGN193109 
resulted in the formation of more robust and organized colonies coupled with a strong 
increase in TBX6-mCherry reporter expression. (n = 3).  Scale bar = 200µm.  
 
 
 
A 
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4.3.2. Gene Expression in FACS Isolated Tbx6+ Cells Supports the Generation of 
Paraxial Mesoderm from H9 Cells 
 To provide greater evidence for the generation of paraxial mesoderm from H9 cells 
and also confirm the fidelity of our transgenic reporter line, we carried out gene expression 
analyses on Tbx6+ and Tbx6- FACS isolated cell fractions (Fig.4.3). Key regulators of 
paraxial mesoderm formation, TBX6 (>300 fold) and MSGN1 (>60 fold) were markedly up-
regulated in the Tbx6+ cell population. While the expression of MEOX1 (>8 fold), a more 
mature marker of paraxial mesoderm was also expressed at higher levels in the Tbx6+ cell 
population. A lower enrichment of BRACHYURY expression in Tbx6+ cells is consistent 
with our studies in mouse ESCs, which potentially identify other mesoderm populations 
where this gene is also expressed (data not shown).  Finally, SOX2 expression is 
extremely low (~35 fold less) in the Tbx6+ cell fraction, which is consistent with past work 
showing that Sox2 repression by TBX6 is necessary for paraxial mesoderm formation28,29. 
 
4.3.3. Effects of cell passage method on stem cell state and downstream 
differentiation potential  
 In an effort to enhance the reproducibility of differentiation studies, we investigated 
alternative cell passaging methods to achieve a more consistent plating density and 
colony size.  We have used Accutase to dissociate colonies into single cells for FACS 
analyses; however, the survival of human ESCs is quite poor when plated as single cells. 
Prior experiments were begun with ESCs as small patches via the “cut and paste” 
method. For this technique, a pipette tip is used to crosshatch stem cell colonies to create 
patches ideally containing fewer than 10 cells. The cells are then mechanically lifted from 
the plate using a cell scraper and collected for plating of the differentiation experiment.  
While the patch passage approach ensures survival, it is very difficult to reliably achieve 
uniform colony size and number between individual wells of the culture plate.  However,  
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Figure 4.3. TBX6 Reporter-Positive Cells Identify Paraxial Mesoderm from Human 
ESCs. Replicate cultures sorted for TBX6-mCherry expression following patch passage and 
four days of treatment with Wnt3a, CHIR99021 and AGN193109. FACS sorting resulted in 
TBX6+ populations of 23.5% and 22.8% of viable cells in each replicate.  Positive and 
negative sorted populations were analyzed for expression of TBX6 and Mesogenin, master 
regulators of paraxial mesoderm specification, MEOX1, a regulator of somite development, 
and SOX2, whose repression by TBX6 is necessary for paraxial mesoderm formation. The 
observed partition of TBX6 and SOX2 in two separate populations is consistent with other 
studies demonstrating the mutual antagonism between these transcription factors. These 
results not only confirm the fidelity of this H9 TBX6-mCherry reporter cell line but show a 
clear transition from an embryonic gene expression profile to expression characteristics 
indicative of paraxial mesoderm differentiation. (n = 3). 
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including thiazovivin, a Rho-associated coiled-coil containing protein kinase (ROCK) 
inhibitor that blocks actin cytoskeleton reorganization, in the plating media greatly 
promoted the survival of Accutase-passaged hESCs and allowed a defined number of 
cells to be seeded in each well.  Interestingly, this manner of single cell passage seems to 
promote a more naïve stem cell state as compared to cells in patches.  Additionally, 
differentiation appeared to progress in a more uniform manner and a robust increase in 
the percentage (88.1%) of TBX6+ cells (Fig.4.4) compared to previous method (~25%, 
Fig.4.3). Expression of endogenous TBX6 was 345-fold higher in the reporter-positive 
population, while MSGN expression increased to 63-fold, both substantially above the 
levels with patch passage.  However, the 9-fold increase in MEOX1 expression in the 
positive population was half that found at the corresponding time point following patch 
passage.  This effect is likely because differentiation initiated on single cells has not 
progressed to the more mature stage of elevated MEOX1 expression.  Furthermore, the 
expression of the tailbud and early mesoderm marker FGF8 is reversed, higher in the 
TBX6 reporter-negative population in Fig.4.3 but higher in the reporter-positive population 
in Fig.4.4.  This reinforces the idea that the single cell passage allows for a more 
synchronous progression of differentiation, and ultimately greater control of downstream 
cell fate.    
 
Identification of cell surface markers that are highly enriched in reporter expressing 
cells is an ideal approach for isolating a highly pure population of cells with specific 
lineage characteristics. Expression of the chemokine receptor CXCR4 (CD184) was also 
25-fold higher in the TBX6+ population (Fig.4.5).  Staining for CXCR4 expression on Day 
4 indicates a majority (78.3%) of the TBX6+ population is also positive for CXCR4 
expression whereas ESC controls and cells not subjected to differentiation factors show  
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Figure 4.4.  Stem Cell State Affects Differentiation and Reporter Expression. 
Passaging as single cells allows for more accurate plating counts and causes a robust 
increase in the TBX6+ sorted population. Endogenous TBX6 expression is also much 
greater at Day 4, and expression of FGF8 is reversed in the sorted populations compared 
to Fig.4.3.  Passaging as single cells may promote a more naïve stem cell state as 
compared to cells in patches and is a potential cause for the increased expression of 
earlier paraxial mesoderm markers and lower expression of the later marker MEOX1, after 
the same differentiation duration and conditions as the prior experiment. (n=3). 
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no TBX6 reporter expression but are also negative for CXCR4 (Fig.4.5).  These results in 
CXCR4 gene expression and surface marker presence were found at much lower levels 
when assessed following differentiation of patch passaged cells, likely due to the 
increased heterogeneity inherent with this method.   
 
4.4. Discussion 
In this study, we showed that the inhibition of RAR signaling through the 
application of the small molecule inhibitor AGN193109 together with activation of the Wnt 
signaling pathway resulted in a robust increase in the formation of paraxial mesoderm 
from mouse and human ESCs. Below we discuss our findings within the context of the 
published literature on paraxial mesoderm formation. 
 
4.4.1 Retinoic acid signaling and paraxial mesoderm 
 Our studies showed that the inhibition of RAR signaling in conjunction with 
activation of the Wnt pathway strongly promoted paraxial mesoderm formation.  Tbx6 
reporter expression markedly increased in human ESCs when AGN193109 was added 
with Wnt3a/CHIR99021 (Fig.4.2).  Additionally, gene markers for paraxial mesoderm 
formation were also notably up-regulated with RAR inverse agonism (Fig.4.3). However, 
treatment with AGN193109, alone, had only a marginal impact on mesoderm induction, 
revealing that this drug, in itself, is likely not a direct mesoderm inducer but augments the 
ability of Wnt signaling to induce paraxial mesoderm.  This suggests that RARs may 
inhibit Wnt signaling possibly through direct and/or indirect mechanisms. In support of this 
idea, past embryonic studies have shown severe axial truncation occurs in the presence 
of excessive levels of retinoic acid79.  Surplus retinoic acid triggers premature 
differentiation of posterior cells leading to insufficient trunk expansion due to exhaustion of 
the posterior progenitor pool.  This caudal progenitor zone exhibits high FGF8 expression  
C 
D 
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Figure 4.5. TBX6 Reporter-Positive Cells are Highly Enriched for CXCR4. Staining for 
CD184 (CXCR4) expression on Day 4 indicates a majority (78.3%) of the TBX6+ population 
(x-axis, mCherry) is also positive for CXCR4 expression (y-axis in bottom panels, APC-A). 
ESC controls and cells not subjected to differentiation factors show no TBX6 reporter 
expression and are also negative for CXCR4. (n = 2). 
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and canonical Wnt signaling through β-catenin to maintain posterior and pre-somitic cell 
characteristics.   However, in response to retinoic acid, RARs are mobilized and bind to 
retinoic acid response elements (RAREs) located upstream of Wnt8a and FGF8 domains 
to mediate gene repression61,116.  In addition, RA has been shown to induce non-canonical 
Wnt signaling that may further antagonize canonical pathway activation leading to loss of 
stemness and expression of genes for differentiation117. This may explain why our 
treatment with Wnt3a and CHIR99021 was far less efficient in generating paraxial 
mesoderm without the addition of AGN193109.   
 
4.4.2. BMP signaling is important for initial mesoderm specification of ESCs 
While BMP signaling was not the primary focus of this study, one of the surprising 
outcomes, which contrasts with other groups, has to do with the importance of inhibiting 
BMP signaling to direct ESCs into paraxial mesoderm.  Our studies showed that treatment 
with the BMP inhibitor Noggin had no benefit for generating paraxial mesoderm from 
mouse ESCs (Fig.3.2) and is actually inhibitory for paraxial mesoderm from human ESCs 
(Fig.4.2).  In contrast, work by others have shown that inhibition of BMP signaling using 
the small molecule inhibitor LDN193189, which targets type I BMP receptors, aids in the 
specification of paraxial mesoderm40,41,118.  In support of their studies, it is well established 
that BMP signaling can redirect the specification of paraxial mesoderm into lateral plate 
mesoderm80.  However, there is also evidence of an earlier positive role for BMP signaling 
in the initial transition of epiblast cells into the primitive streak prior to the specification into 
lateral plate mesoderm119.  Additionally, BMP signaling has been shown to inhibit Sox2 
expression in caudal epiblast cells during their transition into mesoderm28. With this in 
mind and unlike mouse ESCs, human ESCs are biologically similar to the epiblast14.  
Therefore, it is conceivable that BMP signaling plays a key role in the initial conversion of 
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human ESCs out of their fully pluripotent state. Future studies will investigate a possible 
earlier role for BMP signaling in paraxial mesoderm formation. 
 
4.4.3. Initial culture conditions may greatly affect differentiation outcomes  
Stem cell maintenance and passaging protocols can affect the stem cell state and 
lead to variances in the progression of differentiation, even under the same differentiation 
culture conditions and duration.  It is important to understand how different stem cell 
culture techniques can influence the course of a given differentiation protocol. In addition, 
identifying surface markers robustly expressed in reporter positive cells will aid in isolating 
more homogeneous populations moving forward.  Obtaining a uniform population from 
this primary differentiation stage may enhance the ability to generate skeletal progenitors 
through subsequent differentiation stages.   
 
4.4.4. Conclusion  
There is a great interest in understanding how to generate paraxial mesoderm 
from ESCs because derivatives of paraxial mesoderm can give rise to a variety of skeletal 
cell types including chondrocyte, osteoblast, tenocyte, skeletal muscle, and dermal 
fibroblast. Therefore, insights that lead to a breakthrough in the generation of skeletal 
precursors from human pluripotent stem cells has considerable therapeutic implications in 
terms of cell therapy and/or drug development.  Additionally, in vitro models of human 
ESC/iPSC differentiation provide a valuable resource for basic research of human 
development and disease. In these studies, we highlight the value of RAR as an approach 
to increase paraxial mesoderm formation from ESCs. By enhancing the guidance of ESCs 
into paraxial mesoderm, downstream efforts to generate different skeletal cell types will be 
improved. 
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CONCLUSIONS & FUTURE DIRECTIONS 
 
Embryonic stem cell technologies are continually advancing research and the 
development of treatment strategies for human diseases, including those that impact the 
human skeleton.  However, a better understanding of how to direct ESCs into mature, 
functional skeletal cell types remains a necessity as debate persists regarding the most 
appropriate differentiation strategy. Our work has focused on differentiating ESCs along a 
multi-stepped embryonic program in order to gain a better understanding of human 
skeletal development and ultimately obtain higher quality skeletal progenitor cells for 
therapy. This differentiation strategy progresses from ESCs into epiblast and then paraxial 
mesoderm, and eventually into sclerotome and mature progenitor cells.  The progressive 
differentiation of ESCs to simulate their natural maturation during embryonic development 
may not be exclusively novel itself, however few studies specifically focus on the axial 
skeletal lineage21,22.  
 
 We have directed ESCs into paraxial mesoderm through activation of Wnt 
signaling along with inverse agonism of the retinoic acid pathway. Additionally, we have 
demonstrated the utility of first converting ESCs into epiblast cells prior to mesoderm 
induction. This approach is coupled with diagnostic readouts from transgenic reporter cell 
lines, including that for Tbx6, a key regulator of paraxial mesoderm specification.  Such 
stem cell reporter lines allow for real-time visual assessment of the effects of multiple 
culture conditions and also permits FACS analysis and sorting of subpopulations without 
the need for additional antibody staining. We have shown that key paraxial mesoderm 
regulatory genes including Tbx6 and Mesogenin are significantly upregulated in our Tbx6+ 
reporter positive populations, indicating efficient paraxial mesoderm induction as well as 
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reliable reporter function from our differentiation strategy. The ability to isolate a uniform 
population from this primary differentiation stage may allow for more effective generation 
of subsequent sclerotome populations and ultimately, functional skeletal progenitors for 
therapeutic use derived via a differentiation scheme comparable to embryonic 
development.  
 
 A prevailing interest of our work is to understand how different signaling pathways 
regulate the generation of skeletal progenitors. We have focused on the formation of 
paraxial mesoderm because it is the source of embryonic tissue that gives rise to bone, 
cartilage, muscle and tendon of the axial skeleton. RARs are expressed in epiblast cells 
and, during rostral-caudal elongation, in the tailbud of the developing mouse embryo. 
Interestingly, this is a region of the embryo lacks RA signaling yet work by others has 
indicated that RARγ does have a significant role in regulating the rate of paraxial 
mesoderm maturation to properly determine axial length. 
 
Our efforts to differentiate PSCs into paraxial mesoderm have heightened our 
interest in the repressor roles of RARs. Our studies have consistently shown that 
increasing the repressor function of RARs promotes paraxial mesoderm formation. 
However, not until recently have we begun to understand how this happens. Interestingly, 
when mouse embryonic stem cells (mESCs) are differentiated into epiblast cells, the 
addition of AGN193109 (AGN), an inverse agonist that promotes the repressor function of 
RARs, not only results in a more rapid conversion of mESCs into the epiblast state but 
promotes the expression of a certain subset of epiblast gene markers with similarity to the 
caudal lateral epiblast (CLE), while other epiblast markers are down regulated. During 
embryogenesis, maintenance of the CLE is critical for proper axial skeletal elongation15,120.  
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Furthermore, continued differentiation of epiblast cells in the presence of AGN results in 
the up-regulation of unsegmented paraxial mesoderm marker genes Tbx6 and Msgn1.  
However, consistent with the repressor function of RARs, continued AGN treatment 
delays further paraxial mesoderm maturation. 
 
Our work using mouse ESCs revealed two distinct developmental roles for RAR 
signaling during the very early stages of paraxial mesoderm formation. First, RARs can 
influence the differentiation of epiblast cells into a specific kind of epiblast known as the 
caudal lateral epiblast (CLE). Preceding mesoderm formation, cells within the mouse 
epiblast become further specified into distinct subsets, one of which is the CLE, an 
intermediate stem cell population that further differentiates into paraxial mesoderm. 
Second, upon the formation of unsegmented or “presomitic” mesoderm, active RAR 
signaling promotes its further maturation into segmented or “somitic” mesoderm.  Our 
studies show that RAR inverse agonist treatment can arrest differentiation at the 
presomitic stage, delaying maturation into the somitic phase.  Here we propose to further 
investigate which RAR subtype(s) are responsible for coordinating these effects at each 
stage of differentiation. 
 
We have identified an earlier than appreciated role for RARs in mouse epiblast 
cells that is instructive to the formation of paraxial mesoderm. Which RAR(s) mediates this 
function will be an active area of investigation for future studies. To address this gap in 
knowledge, future work will investigate (1) how individual RARs alter epiblast 
differentiation toward the paraxial mesoderm lineage and (2) interrogate directly at the 
DNA level how RARs function in a RA independent fashion to regulate gene expression.  
Specific RARs will be targeted for genetic disruption using CRISPR methods.  The cell 
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lines generated will be used for differentiation studies to scrutinize the functionality of 
individual small molecules and their effect on specific RARs to mediate cell specification. 
Pluripotent stem cells from mouse and human as well as the in vitro culture of mouse 
embryos will be used to examine the repressor role of RARs on epiblast differentiation into 
paraxial mesoderm. This work will provide a much deeper understanding of how RARs 
function independently of RA during early embryonic development.  Additionally, this work 
will determine at the genetic level how RARs function as transcriptional repressors to 
promote paraxial mesoderm formation. In doing so, the field will have a much deeper 
understanding of how skeletal progenitors are generated during embryogenesis and from 
pluripotent stem cells (PSCs). 
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